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The overall objective of this work is to devise a tissue engineering strategy to 
enhance the therapeutic potential of human adipose derived stem cells (ADSCs) 
using three dimensional microsphere (3D) scaffolds and to fabricate such cell-
scaffold constructs into a suitable delivery system for clinical applications. To 
achieve this objective, we initially employed 3D gelatin microspheres (GMs) to 
form compact cell-microsphere constructs (ADSC-GMs) with ADSCs and 
investigated the tissue regenerative properties of those constructs. We 
hypothesized that ADSC-GMs with their strong cell-cell and cell-matrix 
interactions will aid in improving the biological functional abilities of ADSCs.  
Later, to make these constructs feasible for in vivo delivery, we encapsulated them 
into in situ gelling collagen hydrogels to form hydrogel-microsphere composite 
scaffolds (Col-GMs). 
To begin with, ADSC-GM constructs were formed by culturing ADSCs on the 3D 
surfaces of the microspheres and the role of GMs in controlling various properties 
of ADSCs was studied. We studied their proliferation, maintenance of stemness, 
differentiation into various lineages and finally their pro-angiogenic properties. 
All these properties play a key role in tissue regeneration and enhancing such 
properties will be beneficial for tissue regeneration. Firstly, we studied the 
stemness properties of ADSC-GMs by conducting gene expression studies for the 
four well known pluripotent markers genes Oct4, Sox2, Nanog and Rex1. We 
found that all these genes were significantly upregulated in ADSC-GMs while in 
the ADSCs cultured on two dimensional (2D) tissue culture dishes, except Rex1 
all other genes were found to be down regulated. Then we studied the 
differentiation abilities of ADSC-GMs into three different lineages, namely – 
adipogenic, osteogenic and hepatic lineages. Our results show that ADSCs 
cultured on GMs were able to successfully differentiate into all the three lineages 
showing enhanced expression of respective marker genes compared to 2D 
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cultures. Finally, using the in vitro HUVEC-matrigel assay, we demonstrated that 
ADSC-GMs have enhanced pro-angiogenic properties compared to ADSCs 
cultured on 2D. This would lead to better vascularisation of the regenerating 
tissue. In conclusion, this part of our work shows that ADSC-GM constructs have 
enhanced regenerative properties compared to conventional 2D cultures. 
Employing these constructs for treating damaged tissues would accelerate tissue 
regeneration and hence, enhances the therapeutic potential of ADSCs for tissue 
regenerative applications. 
The second part of this thesis focuses on making these constructs with enhanced 
regenerative properties feasible for in vivo delivery, for an easier transition of 
these systems into a clinical setting. To this end, we formed composite hydrogel 
scaffolds (Col-GMs) by encapsulating the ADSC-GMs into injectable, in situ 
gelling collagen hydrogels. Incorporation of GMs into collagen hydrogels varies 
the mechanical properties of the hydrogels and hence allows for tuning the 
rigidity of the hydrogels to provide appropriate mechanical cues for the 
encapsulated cells. In addition, the encapsulated GMs can be used as depots for 
growth factors and can in turn provide with the required biomolecular cues. Thus, 
in this system of Col-GMs, we further studied the effect of mechanical and 
biomolecular cues provided by the scaffolds on the osteogenic differentiation of 
the ADSCs. We found that incorporation of GMs into the collagen hydrogels 
enhances the storage modulus of the hydrogels and further favours osteogenic 
differentiation of the encapsulated ADSCs. Presentation of biomolecular cues 
such as controlled release of basic fibroblast growth factor (bFGF) from the GMs 
also seems to have a promoting effect on the osteogenic differentiation of ADSCs 
compared to bFGF supplementation in the medium. Overall, this part of our study 
shows that Col-GM composite scaffolds can regulate the osteogenic 
differentiation ability of ADSCs and can potentially be used as effective 
injectable delivery vehicles for ADSC-GMs with the ability to control release 
growth factors. 
In conclusion, the work presented in this thesis shows that, 3D GMs can aid in 
enhancing the regenerative properties of the ADSCs along with having the 
potential to take part in the vascularisation of regenerating tissues. Further, we 
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also showed that, osteogenic induction of ADSCs can be enhanced through 
presentation of appropriate mechanical and biomolecular cues in the Col-GM 
composite scaffolds which can in turn be used as delivery vehicles for ADSC-
GMs. Overall, both ADSC-GMs and Col-GM strategies presented in this thesis, 
can be promising approaches for stem cell culture and delivery and can be 
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Figure 2.1 Schematic showing a general sequence of steps involved in 
tissue engineering and regenerative medicine strategies. Cells 
are isolated from the donor tissue sections obtained through 
biopsies which are expanded in vitro and seeded on 3D cell 
culture matrices made of biomaterials to form cell-scaffold 
constructs. In regenerative medicine approach, either aqueous 
cell suspensions or cell-scaffold constructs are directly 
injected back into the patient to assist the natural process of 
tissue regeneration. On the other hand, in tissue engineering, 
such cell-scaffold constructs are then used to fabricate fully 
functional organoid grafts which will be implanted into the 
patients to regain the tissue functions. 
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Figure 2.2 Collagen processing for acidic and basic gelatin preparation. 
Alkaline processing of collagen would yield a negatively 
charged acidic gelatin and an acidic treatment of collagen 
would give positively charged basic gelatin. Depending on 
the requirements of a specific application either type of 
gelatin can be chosen. For example, negatively charged acidic 
gelatin can be used to encapsulate positively charged basic 
biomolecules and vice-versa. Reproduced from (Ikada et al. 
1998) by permission of Elsevier. Copyright © 1998, Elsevier. 
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Figure 2.3 A Schematic representation of gelatin microsphere fabrication 
and cell seeding 
  19 
   
 Figure 2.4 A schematic figure showing the effect of various 
biomechanical cues on stem cell behaviour. Various 
mechanical cues such as mechanical strain, shear stress, 
stiffness and topography seem to act in a synergistic fashion 
to regulate stem cell behaviour. Reproduced from (Kshitiz et 
al. 2012) by permission of The Royal Society of Chemistry. 
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Figure 2.5 A schematic showing various biomolecular cues that are 
present in a stem cell niche that determines stem cell fate. 
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Figure 2.6 A schematic showing microcapsule and microcarrier 
technologies using microspheres. Microencapsulation is 
employed when it is necessary to separate cells from outside 
environment. For example, it is used to prevent the cells from 
getting exposed to immune system of the recipient. 
Microcarriers, on the other hand, allow cell culture on their 
surfaces and forms cell-microsphere contructs with strong 
cell-cell and cell-material interactions which are crucial for 
tissue regeneration.  Reproduced from (Hernandez et al. 
2010) by permission of Elsevier. Copyright © 2010, Elsevier. 
27 
   
Figure 4.1 Optical microscope images of GMs in (a) dry and (b) wet 
condition. (c) SEM image of GMs showing the sphericity of 
the GMs and SEM image in the inset showing the smooth 
surface of the GMs. 
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Figure 4.2 ADSCs cultured on GMs. Optical microscope images of 
ADSC-GMs on (a) day 3 and (b) day 7 of culture period. 
Black arrows showing the bridging of adjacent GMs by 
elongated ADSCs. (c) SEM and (d) CLSM images of ADSC-
GMs on day 7. For CLSM image cell actin was stained with 
phalloidin-TRITC and nucleus with Hoechst. 
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Figure 4.3 (a) Proliferation of ADSCs on 2D (      ) and on GMs (      ) 
studied using total DNA quantification assay. Differences in 
cell numbers on 2D and GMs were not found to be 
statistically significant. (b) qPCR fold change values 
measured relative to day 0 control for stemness marker genes 
Oct4, Sox2, Nanog and Rex1 of ADSCs cultured on 2D and 
GMs after day 3 and day 7. Error bars represent SD (n=3); 
*P<0.05 (student’s t-test) compared to 2D group on day 3 and 
†P<0.05 (student’s t-test) compared to 2D group on day 7.         




   
Figure 4.4 Optical microscope images of Oil Red O staining of ADSCs 
on (a) 2D and on (b) GMs showing adipogenic differentiation. 
Microscope images showing Alizarin red staining of ADSCs 
on (c) 2D and on (d) GMs for detection of osteogenic 
differentiation. qPCR fold change values measured relative to 
day 0 control for adipogenic and osteogenic marker genes (e) 
PPAR-γ and (f) Runx2 respectively on 2D and GMs. Error 
bars represent SD (n=3); *P<0.05 (student’s t-test). 
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Figure 4.5 CLSM images of ADSCs differentiated towards hepatic 
lineage on (a) 2D and on (b) GMs after 2 weeks. For all 
CLSM images cell actin was stained with phalloidin-TRITC 
and nucleus with Hoechst. Hepatic markers were stained with 
respective antibodies tagged with FITC (albumin (ALB), 
alpha-fetoprotein (AFP) and cytokeratin 18 (Cyt18)). The 
dotted circles show the microspheres. (c) qPCR fold change 
values of ADSCs differentiated on 2D and GMs measured 
relative to day 0 control for hepatic marker gene albumin. The 
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Figure 4.6 (a) HUVEC tube formation in two dimensional matrigel 
assay. Representative images of HUVECs seeded on matrigel 
in co-culture with or without ADSC-2D or ADSC-GMs. (b) 
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find out statistical significance. 
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1.1. Background and motivation 
Stem cell therapies are gaining increased popularity over the last decade or so, 
because of the advent of a variety of adult stem cells and the kind of impact that 
such therapies can create on the status quo medical treatments. Adult stem cells, 
unlike embryonic stem cells, are not embroiled with ethical issues and can be 
used in autologous fashion. They can also be easily differentiated to various 
specific cell types and do not form teratomas in vivo. With all these advantages, 
adult stem cells seems to be a potential alternative to embryonic stem cells and 
also opens up a new avenue with immense therapeutic value for treating organ 
failures. 
Adipose derived stem cells (ADSCs) which are present in adipose tissue are one 
such kind of adult stem cells. They are categorized as mesenchymal stem cells 
(MSCs) and have very similar characteristics to that of bone marrow derived 
mesenchymal stem cells (BMSCs) (Kern et al. 2006). ADSCs have a lot of 
advantages compared to other types of adult stem cells, such as availability in 
large numbers, ease of harvesting the fat tissue and their multi-lineage 
differentiation ability (Parker et al. 2006). Typically 5x107 – 6x108 ADSCs can be 
obtained by processing 300 mL of lipoaspirate with very high cell viabilities of 
greater than 90% (Zuk et al. 2001, Aust et al. 2004). All these advantages make 
them an ideal choice of cell source for stem cell regenerative therapies. 
Although stem cell therapies seem to be very attractive, their feasibility of 
becoming a viable medical treatment strategy hinges on being able to overcome a 
few challenges. Firstly, there is a need to develop suitable platforms which can 
support stem cell propagation with proper maintenance of their stemness 
properties and also support their multi-lineage differentiation ability. Secondly, to 
design strategies that makes such in vitro culture platforms suitable for in vivo 
delivery applications by minimally invasive means.  
3 
 
In this thesis, we aim to address mainly these two challenges. We have employed 
three-dimensional (3D) gelatin microspheres (GMs) as cell culture platforms and 
investigated their viability for tissue engineering with ADSCs. To this end, we 
formed cell-microsphere constructs (ADSC-GMs), by culturing ADSCs on GMs 
and further studied some of their properties that play crucial role in tissue 
regeneration – proliferation, stemness maintenance, multi-lineage differentiation 
and pro-angiogenic properties. 
Subsequently, to make the ADSC-GMs more suitable for in vivo delivery, we 
encapsulated them into collagen hydrogels which can gel in situ and can be 
delivered by injectable means. The hydrogel-microsphere composite scaffolds 
(Col-GMs) thus formed have the capability to provide both mechanical and 
biomolecular cues to the encapsulated ADSCs. Appropriate mechanical cues can 
be provided by varying the amount of encapsulated GMs which changes the 
rigidity of the scaffold. On the other hand, the GMs can also be used to control 
release required growth factors and in turn can help in providing the appropriate 
biomolecular cues. Thus in Col-GMs, we also investigated the effect of such 
mechanical and biomolecular cues on the osteogenic differentiation of ADSCs.  
Overall, we believe that the hydrogel-microsphere composite system that we 
developed in this work can be effectively used as an injectable stem cell delivery 
strategy for adipose derived stem cell therapy. 
1.2. Hypothesis 
The three dimensional cell-microsphere (ADSC-GMs) constructs formed using 
ADSCs and GMs with strong cell-cell and cell-matrix interactions can enhance 
the tissue regenerative properties of human ADSCs compared to traditional two 
dimensional tissue culture plates. Also, it is hypothesized that the behaviour of 
such ADSC-GM constructs can be modulated by encapsulating them in collagen 
hydrogels and providing with appropriate mechanical and biomolecular cues. 
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1.3. Objectives  
To investigate the above given hypothesis, following objectives were laid down.  
1) To fabricate ADSC-GM constructs and study the effect of GMs on the 
tissue regenerative properties such as proliferation, stemness maintenance, 
multi-lineage differentiation and pro-angiogenic properties of human 
ADSCs (Chapter 4) 
2) To fabricate and characterize hydrogel-microsphere (Col-GMs) composite 
scaffolds by incorporating GMs in collagen hydrogels with varying 
mechanical and biomolecular cues (Chapter 5). 
a) Fabricate Col-GMs by encapsulating different amounts of GMs in 
collagen hydrogels and study their mechanical properties by 
performing rheological studies. 
b) Encapsulate basic fibroblast growth factor (bFGF) into Col-GM 
scaffolds and study the release profiles in vitro using ELISA. 
3) To study the effect of mechanical and biomolecular cues provided by the 
Col-GM scaffolds on ADSC behaviour (Chapter 5). 
a) Investigate the effect of Col-GMs mechanical properties on ADSCs by 
differentiating them towards osteogenic lineage 
b) Investigate the effect of bFGF controlled release on the osteogenic 














A description of stem cell based tissue regenerative approaches with a 
focus on biomaterials/injectable scaffolds employed for stem cell 









2.1. Tissue engineering and regenerative medicine 
Human organs can get damaged due to various reasons such as diseases or 
accidents. But the only medical treatment approach that is currently under practise 
is organ transplantation. Although surgeons world over have been employing this 
method for a few decades, it is still associated with some severe drawbacks, 
mainly donor organ shortage and immune rejections. To overcome these 
problems, a completely new approach to treat organ failures was put forward by a 
group of clinicians and material scientists which was popularly termed as tissue 
engineering (Langer et al. 1993). The overall objective of tissue engineering as 
coined at the emergence of this field is to fabricate fully functional off the shelf 
tissues which can act as biological substitutes for damaged tissues. Although this 
goal seems to be a few decades away, few significant milestones have already 
been reached, such as generation of induced pluripotent stem cells (iPSCs) 
(Takahashi et al. 2006), isolation of stem cells from adipose (Zuk et al. 2001) and 
other adult organs (Korbling et al. 2003), direct reprogramming of fibroblasts to 
heart (Ieda et al. 2010) and neural cells (Vierbuchen et al. 2010), implantation of a 
tissue engineered airway into a human patient (Macchiarini et al.) and controlled 
design of various scaffolds using biomaterials (Hollister 2005). In slight contrast 
to tissue engineering, regenerative medicine approaches mainly focus on cell 
therapies using suitable delivery vehicles which can support in vivo tissue 
regeneration upon implantation. Various kinds of stem cells are being studied for 
their suitability to such cell therapies which will be discussed in the following 
sections. Over the last decade, tissue regenerative approaches are gaining more 
popularity compared to the highly ambitious tissue engineering motto of “selling 
artificial organs”. Another major area of focus in regenerative medicine has been 
the development of biomaterials which can act as injectable delivery vehicles for 
such cell therapies as well as controlled release biomolecules in a spatio-temporal 
manner, which will also be discussed in the subsequent sections of this chapter. 
The growing interest in the potential of this field is also evident from the increase 
in the number of registered clinical trials in the US which are underway. The 
clinical trials in the field of tissue engineering and regenerative medicine have 
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risen from 38 in 2007 to 83 in 2011 (Fisher et al. 2013). The outcomes of these 
trials will further aid us in assessing the true potential of various approaches that 
are being employed and helps us in taking corrective actions to further improve 
those approaches for clinical applications. 
 
 
Figure 2.1 Schematic showing a general sequence of steps involved in tissue 
engineering and regenerative medicine strategies. Cells are isolated from the 
donor tissue sections obtained through biopsies which are expanded in vitro and 
seeded on 3D cell culture matrices made of biomaterials to form cell-scaffold 
constructs. In regenerative medicine approach, either aqueous cell suspensions or 
cell-scaffold constructs are directly injected back into the patient to assist the 
natural process of tissue regeneration. On the other hand, in tissue engineering, 
such cell-scaffold constructs are then used to fabricate fully functional organoid 




2.2. Stem cells in tissue regeneration 
Cell therapies are fundamental to most of the tissue regenerative approaches and 
finding a reliable source for the supply of cells has been a major area of focus. 
Cells can be harvested from autologous tissues which are partly injured but such 
procedures are associated with intense morbidity. Also, in many instances when 
the tissue is severely damaged, not many good quality cells can be harvested from 
those tissues. Advancements in the field of stem cell biology have opened up new 
options of stem cell based tissue regenerative therapies. As stem cells can be 
induced to differentiate into multiple cell types, the differentiated cells obtained 
can then be used as replacements for the damaged cells within a specific tissue. 
This led to further investigations about the suitability of various types of stem 
cells for such stem cell based therapies, few of which are discussed in the 
following sections. Stem cells are broadly classified into embryonic and adult 
stem cells based on their origin. 
2.2.1. Embryonic stem cells 
Cells with pluripotent nature were isolated from the inner cell mass of the mouse 
embryos and thus were termed as embryonic stem cells (Martin 1981). Later, 
these cells were also isolated from inner cell mass of human blastocysts 
(Thomson et al. 1998) which started all the controversy surrounding ESCs that is 
existent even today. These cells are an ideal source for tissue engineering 
applications as they can self-renew indefinitely and can differentiate into cell 
types of all the three germ layers. However, there are major drawbacks associated 
with these cells such as the ethical issues, teratoma formation upon in vivo 
implantation and their allogenic source which invokes immune response. These 
drawbacks limit their wider usage for clinical applications. 
2.2.2. Adult stem cells 
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Stem cells that regularly take part in the replenishment of dead cells and in the 
regeneration of damaged tissues have been found to be present in many tissues of 
the adult body. Depending on the type of stem cell, their differentiating capacity 
and their potency will vary. Some cells can differentiate into only one specific 
lineage and are termed as progenitor cells. Other stem cells from some tissues are 
multipotent and can give rise to cells that are not related to their source tissue. For 
example, bone marrow (Pittenger et al. 1999) and adipose (Zuk et al. 2002) 
tissues are two widely popular sources for mesenchymal stem cells which can 
give rise to a wide variety of cell types. Many adult stem cells are proving to be 
promising alternatives for ESCs because of their similar differentiation abilities, 
ease of availability and being able to be used in autologous fashion. However, 
harvesting cells from adult tissues obtained through biopsies involves some 
problems such as morbidity and low cell numbers. Thus for clinical applications, 
it will be advantageous to find ways to harvest tissues by minimally invasive 
means which contain large numbers of stem cells. 
2.2.3. Adipose derived stem cells 
ADSCs are adult stem cells found in adipose tissues with very similar 
characteristics to BMSCs. They were first isolated in 2001 (Zuk et al. 2001) and 
since then they were gaining increased popularity over other adult stem cells 
because of many advantages. Adipose tissues can be harvested by minimally 
invasive means such as liposuction with local anaesthesia. This makes ADSCs to 
be easily available compared to other stem cells and can be used in autologous 
fashion. They are also available in very high densities in fat tissues with typical 
cell numbers of around 5x107 – 6x108 from 300 ml of lipoaspirate (Zuk et al. 
2001, Aust et al. 2004) which is approximately 40 times higher compared to 
BMSCs (Strem et al. 2005). In addition, ADSCs also seem to have higher 
immunomodulatory capacity compared to BMSCs (Melief et al. 2013). They also 
exhibit high proliferation rates along with multi-lineage differentiation ability 
(Zuk et al. 2002). With all these advantages, ADSCs are proving to be a 
promising cell source for tissue regenerative applications and are being widely 
investigated both at lab scale and also at clinical scale (Gir et al. 2012). 
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ADSCs have been shown to be able to differentiate into various lineages 
including adipogenic, osteogenic, chondrogenic, myogenic, neural and hepatic 
cells (Talens-Visconti et al. 2007, Bunnell et al. 2008a, Cardozo et al. 2012, Sung 
et al. 2013). While the differentiation into former three lineages has been widely 
known and has well established protocols, differentiation into the later three 
lineages is more challenging and is currently under study by various research 
groups. In this thesis, we attempted differentiating ADSCs into hepatic lineage 
along with adipogenic and osteogenic lineages on 3D gelatin microspheres with 
an objective of making use of such differentiated cell-microsphere constructs for 
liver, fat and bone tissue reconstruction.  
2.2.4. Hepatic differentiation of ADSCs 
Liver tissues have a unique ability to regenerate after an injury. Hepatocytes and 
liver progenitor cells are the main cells responsible for the regenerative feature of 
liver. In case of an acute injury, hepatocytes will first respond with high 
proliferating rates (Fausto et al. 2005). Liver progenitor cells will form a reserve 
pool of cells which will start to proliferate and differentiate in case of a failure in 
hepatocyte proliferation (Roskams et al. 2003). However, in case of end stage 
liver disease, most of liver cells gets damaged and the liver looses the ability to 
regenerate. In such cases, stem cell transplantation is being looked into as a 
potential treatment strategy. ADSCs are being studied for their ability to 
differentiate into hepatocytes because of their advantages over other stem cells as 
mentioned in previous section. In 2005, Seo et al. has first shown that, human 
ADSCs can be induced towards hepatic lineage using hepatocyte growth factor 
and oncostatin M as media supplements (Seo et al. 2005). Since then, there has 
been increased interest in the hepatic potential of ADSCs and different 
combinations of growth factors have been tried (Talens-Visconti et al. 2007, 
Yamamoto et al. 2008, Aurich et al. 2009, Coradeghini et al. 2010, Banas 2012). 
However, most of the studies were performed on 2D tissue culture dishes with 
very few in 3D scaffolds. For instance, Wang et al. has studied hepatogenesis of 
ADSCs in 3D PLGA scaffolds (Wang et al. 2010). From tissue engineering 
perspective, it is important to understand the hepatic potential of ADSCs in 3D 
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scaffolds and thus more such studies need to be performed in scaffolds made of 
various biomaterials. Such differentiated hepatocyte-scaffold constructs can in 
turn be used as implants for treating liver damages and also for conducting drug 
screening studies.  
2.2.5 Characterization methods for adipogenic, osteogenic and hepatic 
differentiation of ADSCs 
Characterization of stem cell differentiation is usually done by histochemical 
staining methods or by studying the expression of specific lineage marker genes 
or proteins. Various methods that are most commonly employed for 
characterizing adipogenic, osteogenic and hepatic differentiation of ADSCs is 
discussed below.  
Adipogenic differentiation of ADSCs can be very easily identified under an 
optical microscope by the deposition of lipid bodies inside the differentiated 
ADSCs. Such lipid bodies can further be stained using Oil red O stain to have a 
distinct appearance. For further in depth characterization, gene expression of 
adipogenic marker genes such as peroxisome proliferative activated receptor γ 
(PPAR-γ), fatty acid-binding protein 4 (FABP4) and lipoprotein lipase  can be 
studied using qPCR (Hu et al. 2011b). In addition, as glycerol-3-phosphate 
dehydrogenase (GPDH) activity is increased upon adipogenic differentiation, 
GPDH assay can also be employed for characterizing the extent of differentiation.  
For characterizing osteogenic differentiation of ADSCs histochemical staining 
methods using alizarin red S and von kossa are usually employed to visualize the 
mineralized matrix deposition of differentiated ADSCs. Both alizarin red and von 
kossa can bind to the mineral depositions produced by the differentiated 
osteoblasts. Von Kossa method is based on binding of the silver ions to the anions 
such as phosphates of calcium salts and the reduction of silver salts to form dark 
brown or black metallic silver staining. On the other hand, alizarin red S reacts 
directly with calcium cation to form a chelate. Further characterization can be 
done by studying the genetic or protein level expression of osteogenic markers 
such as runt-related transcription factor 2 (Runx2), alkaline phosphatase (ALP), 
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bone morphogenetic protein 2 (BMP2), osteopontin (OPN) and osteocalcin 
(OCN) (Hu et al. 2011b).  
Hepatic differentiation of ADSCs can be characterized using Periodic acid-schiff 
(PAS) staining to identify the glycogen storage ability of the hepatic differentiated 
ADSCs. In addition, gene or protein level expression of various hepatic markers 
such as albumin (ALB), alpha-fetoprotein (AFP), cytokeratin 18 (Cyt18), 
transthyretin (TTR) (Banas et al. 2007), can also be studied for characterizing 
hepatic differentiation.  
2.3. Biomaterial scaffolds for Stem cell therapies 
Traditionally, many of the studies involving stem cells have been performed on 
2D tissue culture plates. Although such studies have provided us with most of the 
existing knowledge of stem cell biology, they have certain limitations. Firstly, 
these culture systems cannot fully replicate the in vivo milieu which mainly 
consists of extra cellular matrix (ECM) that provides a unique biological niche for 
the cells to adhere and differentiate. Secondly, such stem cells cultured on 2D, 
have also proven to be in efficient for tissue regeneration (Lee et al. 2008, 
Mooney et al. 2008). Further, direct injection of such cell suspensions has lead to 
the death of the transplanted cells in many instances (Guerette et al. 1997, Emgard 
et al. 2003). Shortage of cell-matrix interactions leading to anoikis was found to 
be the reason for such cell death (Terrovitis et al. 2010). On the contrary, stem 
cell delivery using 3D delivery vehicles which can support cell adhesion were 
able to improve the survival rate and their tissue regenerative ability (Zakharova 
et al. 2010, Parisi-Amon et al. 2013). This highlights the need for developing 3D 
delivery platforms which can mimic the ECM. The materials for developing such 
3D platforms also have to be biocompatible as well as biodegradable which are in 
turn termed as biomaterials. Such biomaterials play an important role in the 
development of 3D platforms which along with being able to deliver the stem 
cells, they can also control stem cell behaviour by presenting appropriate 
biochemical cues. Biomaterial scaffolds can provide a 3D framework for the stem 
cells to propagate, differentiate and allows for remodelling of the surrounding 
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matrix upon action by the cells to form an implantable functional organoid. 
Numerous biomaterial scaffolds have been designed to drive the stem cells toward 
a particular lineage. For example, 3D systems were able to enhance the osteogenic 
(Sun et al. 2014), myogenic (Liu et al. 2012), neural (Cheng et al. 2013) and 
chondrogenic (Dvorakova et al. 2013) differentiation of various stem cells. In 
addition, these 3D platforms can also aid in forming stronger cell-cell and cell-
matrix interactions. Further, the interactions of biomaterials with biomolecules 
have also been exploited to encapsulate various growth factors for presenting 
appropriate biomolecular cues to control stem cells (Fan et al. 2008). Because of 
all these advantages, 3D biomaterial scaffolds have become the basis for most of 
the stem cell therapy strategies of late. Often, such scaffolds are designed to allow 
for stem cell delivery through less invasive methods such as by injectable means.  
Biomaterials used to fabricate the 3D culture platforms can be broadly classified 
into two types – natural and synthetic. Materials will have to be chosen according 
to the existing requirements of a specific application at hand. Properties of the 
biomaterials such as fluid transport, material degradation, surface chemistries for 
cell adhesion, mechanical strength, interaction ability with cells to induce signals, 
interactions with biomolecules for their controlled delivery need to be taken into 
consideration while choosing a biomaterial for any application (Dawson et al. 
2008). Overall success of a stem cell therapy associated with biomaterial 
scaffolds would hinge upon the above mentioned material properties as they can 
determine the fate of many key processes such as nutrient diffusion, matrix 
remodelling, cell adhesion and differentiation. A large variety of biomaterials 
both natural and synthetic have been employed for stem cell cultures which are 
discussed in the following sections.  
2.3.1. Synthetic biomaterials 
Polymers and ceramics are two of the widely used synthetic matrices for stem cell 
therapies. While various types of polymers have been employed for many 
different types of tissue regenerative applications, ceramics such as calcium 
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phosphates are mainly employed for bone regeneration. Ceramics can provide 
higher mechanical strength and also have shown to enhance mineralization and 
matrix formation along with integrating well with the bone (Yuan et al. 2001, 
Arinzeh et al. 2005). On the other hand polymeric materials have been employed 
both for soft and hard tissue regeneration using stem cells. Polymers such as 
polyethylene glycol (PEG), polyglycolic acid (PGA), polylactic acid (PLA), 
polylactide-co-glycolide (PLGA), polycaprolactone (PCL) are some of the widely 
used ones for stem cell therapies. All these polymers are usually degradable in 
nature by hydrolysis and their degradation products formed are able to be 
physiologically removed. In addition, the main advantage of using synthetic 
polymers is that their degradation rates can be precisely controlled by 
manipulating the polymer chemistry and molecular weights (Lyu et al. 2009). 
Further, properties of these polymeric 3D scaffolds such as porosity, mechanical 
properties etc. can also be effectively tuned to fulfil the requirements of a specific 
application (Saha et al. 2007). However, although culture matrices made of 
synthetic materials provide good control over their physico-chemical properties, 
they are not bioactive by nature. Most of these matrices need to undergo 
biological or chemical modification to support cell culture and elicit a favourable 
cellular response. On the contrary, natural materials extracted from ECM are 
supportive of cell culture and are biologically active without the need for any 
modifications.  
2.3.2. Natural biomaterials 
ECM present in human bodies mainly consists of components such as collagen, 
fibrinogen, hyaluronic acid, heparin sulphate, chondroitin sulphate, 
glycosaminoglycans etc. Hence, most of these materials extracted from the ECM 
of different animal sources have been tried as culture platforms for culturing stem 
cells under in vitro conditions in order to mimic and create an in vivo like 
environment. Some other materials such as cellulose, chitosan and silk fibroin 
which are extracted from plants, other animals or insects have also been employed 
to fabricate 3D scaffolds for stem cell culture and differentiation. Although 
natural materials are very good at providing an in vivo mimicking culture 
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platform, they are also associated with some disadvantages. As most of these 
materials are extracted from animal sources there is chance for transmission of 
pathogens from animals to humans. Other drawbacks of natural materials include 
the difficulty in their purification and lack of complete control over their physico-
chemical properties. However, lately many of these concerns have been addressed 
because of their commercial availability by many chemical companies which have 
set up standard protocols for the production of these materials with reproducible 
properties and with no carryover of pathogens.  
Most typical of the commercially available natural materials are collagen and its 
derivatives. Collagen is the most abundant protein in the ECM of our body and 
thus 3D scaffolds made of collagen or its derivatives were believed to closely 
simulate the body conditions. In total, twenty seven collagen types have been 
identified till now (Koide 2007) among which type I collagen is the most 
abundant and widely employed one for biomedical applications. It was also found 
that very few people possess humoral immunity against type I collagen and 
vulnerability of a patient to it can be easily found out by a serological test before 
implantation (Parenteau-Bareil et al. 2010). Along with mimicking the native 
ECM, the chemical nature of collagen has also made it suitable for crosslinking 
using various chemical agents (Drury et al. 2003). This property of collagen 
permits for tailoring the mechanical and degradation properties of collagen based 
scaffolds as per specific requirements, and thus has attracted much attention for 
various biomedical applications including stem cell therapies. 
Collagen has been widely used to fabricate different types of scaffolds such as 
hydrogels (Egawa et al. 2011), microspheres (Hui et al. 2008), nanofibers (Shih et 
al. 2006) etc. which were used extensively for various stem cell associated 
applications. In addition, over last decade or so, many collagen based tissue 
engineering products have been developed and commercialized by various 
companies (Malafaya et al. 2007). For example, a product named Apligraf®, 
which is a bilayered collagen gel seeded with fibroblasts and keratinocytes has 
been commercialized by Organogenesis in USA as artificial skin and got its FDA 
approval in 1998. Similarly, inFUSE® Bone Graft has been commercialized by 
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Medtronic Sofamor Danek which is a collagen sponge that acts as carrier for 
BMP-2 for spinal fusion. Angiotech Pharmaceuticals, Inc. in Canada has 
commercialized a composite made of porous hydroxylapatite, tricalcium 
phosphate and type I collagen under the name of Collagraft®. Many other 
collagen based products have also been commercialized or are under development 
by various companies for a wide range of applications including cosmetic 
products, skin replacements, bone and periodontal tissue grafts (Malafaya et al. 
2007). All these examples which have been approved for clinical usage highlights 
the immense potential of collagen based scaffolds, firstly as promising 
biomaterials for several tissue regenerative applications and secondly for its 
translational ability to clinical stage. 
Another prime derivative of collagen that has been widely used in tissue 
engineering is gelatin. Gelatin is a natural polymer obtained from collagen upon 
acid or alkaline processing. Gelatin is biodegradable, biocompatible and has been 
in regular usage for pharmaceutical and medical applications since long time. Its 
biosafety has been well proved from its usage as a plasma expander, as a 
component in drug formulations and also as a sealant in vascular prosthesis 
(Young et al. 2005).  Gelatin also carries the key cell adhesion moieties, present 
in collagen and thus supports cell attachment and proliferation. Depending on the 
fabrication method employed two types of gelatin can be obtained (Figure 2.2), 
both of which are commercially available. Alkaline processing of collagen would 
yield a negatively charged acidic gelatin and an acidic treatment of collagen 
would give positively charged basic gelatin. Both types of gelatin are suitable for 
cell culture and basically differ in the electrostatic and physical properties. 
Depending on the application the type of gelatin need to be chosen appropriately. 
The different varieties of gelatin scaffolds used for stem cell applications and the 






Figure 2.2 Collagen processing for acidic and basic gelatin preparation. Alkaline 
processing of collagen would yield a negatively charged acidic gelatin and an 
acidic treatment of collagen would give positively charged basic gelatin. 
Depending on the requirements of a specific application either type of gelatin can 
be chosen. For example, negatively charged acidic gelatin can be used to 
encapsulate positively charged basic biomolecules and vice-versa. Reproduced 
from (Ikada et al. 1998) by permission of Elsevier. Copyright © 1998, Elsevier. 
Different types of scaffolds such as hydrogels, nanofibres and microspheres have 
been fabricated using gelatin alone or in combination with other biopolymers for 
tissue engineering applications (Kimura et al. 2003, Li et al. 2006, Liu et al. 2009, 
Hirai et al. 2013). Gelatin has a sol-gel transition of around 20 oC, and hence for 
gelatin scaffolds to keep their structure intact at body temperatures they need to 
be crosslinked. A variety of crosslinking agents have been tried such as 
glutaraldehyde, diisocyanates, carbodiimides, genipin etc. Alternatively, gelatin 
can be modified with methacrylate and can be crosslinked using UV in the 
presence of a photoinitiater (Lin et al. 2013). Many gelatin scaffolds have been 
previously employed for stem cell culture, differentiation and delivery. For 
example, gelatin/poly(ethylene glycol) biomatrices have been developed to 
deliver MSCs for wound healing (Xu et al. 2013). Scaffolds formed with gelatin 
and β-tricalcium phosphate or hydroxyapatite have been used for bone 
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regeneration using stem cells (Takahashi et al. 2005, Eslaminejad et al. 2007, 
Bernhardt et al. 2009). Electrostatic interactions of gelatin with the biomolecules 
can be used for encapsulation of various growth factors in gelatin scaffolds. Due 
to such electrostatic interactions gelatin can form strong poly-ion complexes with 
the oppositely charged biomolecules (Young et al. 2005). Negatively charged 
acidic gelatin can be used to encapsulate positively charged basic biomolecules 
and vice-versa. Thus depending on the kind of biomolecular cues that need to be 
presented for regulating stem cell behaviour, appropriate type of gelatin can be 
chosen. Gelatin microspheres have been well known as the most suitable of 
gelatin based scaffolds for control release of biomolecules. 
2.3.3. Gelatin Microspheres 
Microsphere scaffolds in general have certain unique features and advantages 
compared to other scaffold types. They tend to get their 3D nature through the 
curvature of the spheres which seem to have an enhanced effect on various 
cellular processes such as proliferation and differentiation (Schmidt et al. 2011). 
They can also be used as effective drug delivery vehicles and can control release 
various biomolecules. Thus microsphere scaffolds can usually be employed as 
delivery vehicles for both cells and growth factors simultaneously (Chen et al. 
2010). This kind of an approach can be very beneficial for tissue regeneration as it 
can aid in three different ways. The microspheres can be packed together to form 
organoid constructs of required shape and size and depending on the material 
used for microsphere fabrication, they can aid as temporary replacements for the 
lost ECM of the damaged tissue. The cells and growth factors that are delivered 
using microsphere scaffolds can aid in regeneration by replenishing the lost 
functional cells and biomolecular signals within the tissue. Certain growth factors 
such as hepatocyte growth factor can even aid in recruiting the endogenous stem 
cells from the adjoining tissues (van de Kamp et al. 2013). Control release of 
growth factors such as vascular endothelial growth factor (VEGF) and basic 
fibroblast growth factor (bFGF) can take part in the vascularization of the tissue 




Microsphere scaffolds made of gelatin termed as gelatin microspheres (GMs) are 
well known for their drug delivery abilities for various disease conditions (Jian 
Wang 2000, Vandelli et al. 2001, Nakase et al. 2002). GMs have also been 
successfully employed previously in various clinical trials (Nitta et al. 2009, 
Toyama et al. 2012) and thus regenerative systems made from them can have a 
better chance to succeed at clinical level compared to many other commercially 
available microcarriers. Recently they have also been employed for various tissue 
engineering applications and proven successful for delivering growth factors to 
enhance chondrogenic differentiation of MSCs (Fan et al. 2008). In this thesis, we 
employed GMs for enhancing the regenerative properties of ADSCs by forming 
cell-microsphere constructs. Microsphere scaffolds are also known to form strong 
cell-microsphere constructs which enhances the cell-cell and cell-matrix 
interactions (Zhu et al. 2007a, Zhu et al. 2007b, Zhu et al. 2008). Such 
interactions play a key role in tissue regeneration (Chen et al. 2012) and further 
shown to have improved the biological functions of stem cells (Hayashi et al. 
2011). In a similar effort, in this thesis we studied if such strong cell-cell and cell-
matrix interactions in the cell-microsphere constructs formed by ADSCs and GMs 
will enhance the biological functions of ADSCs which can further lead to 
accelerate the tissue regeneration process.  
 





2.4. Injectable delivery systems for stem cell therapy 
Two kinds of approaches are primarily under consideration for stem cell therapies 
– (i) injection of stem cells with aqueous media to the wound site and (ii) 
injection of stem cells using 3D delivery systems. Direct injection of stem cells 
alone has previously caused cell death in certain instances (Guerette et al. 1997, 
Emgard et al. 2003) and proven ineffective for tissue regeneration (Lee et al. 
2008). Injection of stem cells using 3D delivery vehicles which can provide cell 
adhesive sites were able to avoid cell death and also able to localise high densities 
of stem cells at the site of injury (Zakharova et al. 2010, Parisi-Amon et al. 2013). 
Such delivery vehicles can also provide a unique stem cell niche which can 
modulate stem cell response. Along with inducing stem cells to differentiate into a 
certain lineage of the damaged tissue, the micro-architecture of 3D systems can 
also regulate the growth factor secretion profiles of the stem cells (Guilak et al. 
2009) which can aid in the tissue regeneration through paracrine signalling 
(Ratajczak et al. 2012).  
Other advantages of such injectable delivery systems from a clinical perspective 
include ease of administration with significant reduction in treatment time, cost 
and patient morbidity along with smaller scar sizes and faster recovery (Fuchs 
2002). Other than cell delivery, such injectable scaffolds can also be utilized as 
fillers for scar corrections, embolization agents, and also as in house biosensors 
(Munarin et al. 2012). Due to all these reasons, injectable delivery systems which 
can be employed with minimally invasive surgeries are becoming more attractive 
in the medical field for cell and drug delivery applications.  
The effect of micro-architectural niche which include mechanical and 
biomolecular cues provided by these injectable delivery systems on the stem cell 




2.4.1. Effect of mechanical cues on stem cells 
Stem cells can sense and respond to the physical micro-environment surrounding 
them. MSCs were found to be the most receptive stem cells which regularly 
encounter various kinds of physical forces inside the body, such as hydrostatic 
pressure, diffusive mass transport, shear stress etc. which drive them towards 
proliferation or differentiation and play a crucial role in the development of 
various tissues (Higuera et al. 2012). MSCs have the ability to differentiate into a 
wide variety of cell types ranging from neurons to osteocytes depending on the 
matrix stiffness (Engler et al. 2006). Matrices which are soft tends to induce 
neural lineage while stiffer and rigid matrices induces myogenic and osteogenic 
lineages respectively (Engler et al. 2006). This kind of a signalling from the 
matrix to the cells happens through large macromolecular assemblies of integrins 
called focal adhesions. Focal adhesions act as mechanical links between the 
surrounding matrix and the cytoskeleton of the cells and aid in transforming 
mechanical signals into biochemical signals by triggering various mechano-
transduction pathways (Sun et al. 2012). Such biochemical signals then gets 
propagated to the cell nucleus which further regulates the stem cell behaviour by 
effecting the gene expression (Wang et al. 2009b). 
The role of mechanical cues in determining stem cell fate has been exploited in 
various stem cell based tissue regenerative strategies. For example, mechanical 
properties of collagen-hyaluronic acid composite hydrogel scaffolds were tailored 
to direct the differentiation towards neuronal cells or glial cells for neural tissue 
regeneration (Her et al. 2013). Polyacrylamide gels conjugated with 
decellularized human lipoaspirates have been employed to stimulate adipogenesis 
of human ADSCs in the absence of any adipogenic growth factors by mimicking 
the native stiffness of adipose tissue (Young et al. 2013).  Many other studies 
have also successfully demonstrated the induction of a specific cell type by 
providing with appropriate mechanical cues through injectable scaffolds (Ghosh 





Figure 2.4 A schematic figure showing the effect of various biomechanical cues 
on stem cell behaviour. Various mechanical cues such as mechanical strain, shear 
stress, stiffness and topography seem to act in a synergistic fashion to regulate 
stem cell behaviour. Reproduced from (Kshitiz et al. 2012) by permission of The 
Royal Society of Chemistry. Copyright © 2012, The Royal Society of Chemistry. 
2.4.2. Effect of biomolecular cues on stem cells 
Along with mechanical cues, biomolecular cues also play an important role in 
determining the fate of the stem cells. During the initial weeks stem cells respond 
to the soluble induction factors and later on, the matrix elasticity drives the 
induction towards a certain lineage (Engler et al. 2006). Various types of 
biomolecules are being employed for different applications ranging from 
vascularisation to recruiting endogenous stem cells. VEGF is a well known 
angiogenic growth factor which can also induce endothelial differentiation in 
MSCs (Wang et al. 2013b). Chemokines such as stromal cell derived factor 1, can 
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recruit endogenous stem cells at the injury site and aid in the wound healing 
process (Imitola et al. 2004, Otsuru et al. 2008). At present, growth 
factors/cytokines are the most widely used biomolecular cues in tissue 
engineering strategies to induce different types of stem cells into all most all cell 
types of human body. In addition, cell adhesive motifs are also being employed 
by conjugating them with synthetic matrices to make them suitable for stem cell 
attachment and further to regulate the stem cell properties such as cell shape, 
migration and differentiation (Bacakova et al. 2004). 
 
Figure 2.5 A schematic showing various biomolecular cues that are present in a 
stem cell niche that determines stem cell fate.  
Hydrogels and microspheres are the two widely used 3D scaffolds which are well 
known for providing mechanical as well as biomolecular cues and can also be 
employed as injectable stem cell delivery systems are discussed in the following 
sections. 
2.4.3. Hydrogels for stem cell therapy 
Hydrogels are 3D scaffold materials which are made of hydrophilic polymers and 
are known to absorb high amounts of water. These matrices can closely resemble 
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physiological conditions with a proper selection of a biomimetic material which 
have tunable mechanical properties as well as high water content. They can be 
fabricated in different forms such as micro/nanoparticles or in the form of soft 
gels which can be injected in a liquid form and can gel in situ at the wound site 
(Hoare et al. 2008). This property of in situ gelling makes them an ideal choice to 
be used as fillers as they can take the appropriate shape of the defect site. They 
can also encapsulate stem cells and growth factors (Hwang et al. 2013a) and thus 
be effectively employed for stem cell therapies. A solution of gel precursors, stem 
cells and biomolecules can be injected into the body using a syringe and allowed 
to gel at the injury site. Once gelled, the 3D construct can provide appropriate 
chemical, mechanical, and biomolecular cues to enhance the regenerative 
potential of the encapsulated stem cells. The growth factors either encapsulated or 
secreted by the stem cells can also take part in the tissue regeneration either by 
recruiting endogenous stem cells or by improving vasculature through paracrine 
means. 
Suitable materials need to be selected for fabrication of hydrogels for stem cell 
therapy based on the following criteria (Li et al. 2012). Firstly, the material 
should be biocompatible and biodegradable without release of any toxic by 
products upon degradation. Secondly, the viscosity of the materials should be 
reasonably low for them to be smoothly injectable and should be able to make a 
sol-gel transition under physiological conditions at appropriate gelation rates. 
Thirdly, the mechanical properties and degradation rates of the material should be 
tunable to fabricate them in compliance with the requirements of a specific 
application. Fourthly, it will also be advantageous if they can support controlled 
release of growth factors over desirable periods. Fifthly, the gel construct formed 
should have an appropriate porous structure for cell migration and also to support 
the exchange of nutrients as well as removal of waste. 
Polymeric materials of both natural and synthetic origin have been employed 
previously for developing such injectable stem cell delivery systems. Natural 
polymers including chitosan, hyaluronic acid, alginate, collagen, gelatin, heparin 
and fibrin have been employed (Lee et al. 2001). Among the synthetic polymers, 
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peptides which can self assemble to form hydrogels have been employed but they 
are often expensive. Derivatives and co-polymers of poly(acrylic acid), poly(vinyl 
alcohol) (PVA), PEG and PCL have also been employed for making hydrogels for 
stem cell applications (Lee et al. 2001). 
2.4.4. Microspheres for stem cell therapy 
Microspheres have been used for the stem cell delivery in two ways – 
microencapsulation and microcarriers. In microencapsulation, cells are 
encapsulated inside the microspheres and in microcarrier cultures, cells are 
cultured on the surface of the microspheres. Both the approaches are discussed 
below. 
Microencapsulation is a strategy which is usually employed when it is necessary 
to strictly separate the cells from the outside environment. For example, it can be 
used for cell delivery across immunological barriers (Jeon et al. 2006). 
Microencapsulation aids in avoiding the cells to come into contact with the host’s 
immune system and thus can subside immunological issues. This approach also 
avoids the use of immunosuppressive drugs and also allows choosing the cells 
from a large variety of sources including allogenic and xenogenic sources (Zhang 
et al. 2008). However, escape of allogenic or xenogenic cells from the 
microcapsules due to excessive cell proliferation or degradation of the capsule 
might expose them to the host’s immune system which might then attack those 
cells. Microencapsulation has also been employed for stem cell delivery using 
microcapsules termed as “artificial cells” which are capsules encapsulated with 
stem cells surrounded by strong and thin multilayer membrane components for 
nutrient transport (Paul et al. 2009). Materials employed for fabricating 
microspheres for this approach are usually hydrophilic polymers that form 
hydrogels. This permits the cells to be encapsulated in a hydrated environment 
which supports cell proliferation and migration. However, the main challenge in 
this strategy is the seeding of the cells into microspheres. If the cells are added to 
the precursor solution before fabricating microspheres, the cells have to bear the 
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harsh processing steps which might severely reduce the cell viability.  Another 
approach is to seed the cells on the surface and allow the cells to migrate into the 
microspheres through the pores, which limits the uniform distribution of cells 
throughout the scaffold and will not permit optimal cell seeding densities.  
In addition to microencapsulation, microsphere scaffolds can also be used as 
microcarriers for cell delivery by culturing the cells on the surface of 
microspheres. Such an approach will also allow to simultaneously encapsulate 
growth factors in the microspheres and controlled release them to present 
appropriate biomolecular cues to the cells cultured on the microsphere surface. 
For example, heparin crosslinked chitosan microspheres have been employed to 
deliver neural stem cells along with bFGF for central nervous system repair (Skop 
et al. 2013). This approach also forms cell-microsphere aggregates with strong 
cell-cell and cell-matrix interactions which proves to be crucial for tissue 
regeneration (Bratt-Leal et al. 2011). However, disadvantage of this kind of an 
approach is as the cells are exposed directly to outside environment, the shear 
forces during injection might effect the cells and might also detach the cells from 
microspheres which limits their usage as injectable delivery systems. In addition, 
maintaining the cell-microsphere constructs at the site of injury has also been 




Figure 2.6 A schematic showing microcapsule and microcarrier technologies 
using microspheres. Microencapsulation is employed when it is necessary to 
separate cells from outside environment. For example, it is used to prevent the 
cells from getting exposed to immune system of the recipient. Microcarriers, on 
the other hand, allow cell culture on their surfaces and forms cell-microsphere 
constructs with strong cell-cell and cell-material interactions which are crucial for 
tissue regeneration.  Reproduced from (Hernandez et al. 2010) by permission of 
Elsevier. Copyright © 2010, Elsevier. 
2.4.5. Hydrogel-Microsphere composite scaffolds 
Although both hydrogels and microspheres have been independently employed 
for stem cell delivery applications on many occasions as indicated in the above 
sections, they are also associated with some drawbacks which need to be 
overcome. For example, the mechanical strength of the traditional hydrogels is 
poor. Traditional approaches of crosslinking have improved their mechanical 
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strength but the crosslinking methods employed are often toxic to cells and thus 
effects the cell viability for in situ cell encapsulation. On the other hand, although 
microspheres have been proved effective as drug and cell delivery vehicles, 
maintaining them at the injury site seems challenging. In some instances, they 
were found in distant organs from where they were injected (Pannek et al. 2001). 
This kind of migration of cell-microspheres might lead to deleterious effects in 
other tissues.  
To overcome the issues associated with both these systems, integrated delivery 
systems can be developed by a combination of these two techniques. Cells can be 
cultured on the surface of the microspheres and can be encapsulated in a hydrogel 
environment. The hydrogel network provides a 3D microenvironment for cells to 
proliferate and migrate and microspheres can be used as depots for growth factor 
delivery. The soft hydrogel surrounding the cell-microsphere constructs will also 
facilitates a minimally invasive means of delivery along with permitting for in 
situ gelation and cell encapsulation. Once gelled, the hydrogel can aid in 
maintaining the cell-microsphere constructs at the wound site and can also 
regulate the stem cell behaviour by providing with suitable mechanical and 
biomolecular cues. For example, PLGA microparticles encapsulated in collagen 
hydrogels (DeVolder et al. 2012) and TGF-β3 loaded alginate microspheres 
encapsulated in hyaluronic acid hydrogels (Bian et al. 2011) have been previously 
employed for bone and cartilage regeneration respectively using MSCs. 
Sequential delivery of growth factors can also be attained by loading different 
growth factors in hydrogel matrix and in microspheres (Kim et al. 2012). 
However, such an approach of hydrogel-microsphere composite systems for stem 
cell delivery has been relatively less studied. As discussed in the above sections 
2.3.2 and 2.3.3, collagen hydrogels and GMs have been widely used for stem cell 
based tissue engineering applications and have high degree of potential to get 
translated to clinical level. Hence, in this thesis we examined the effect of such a 
composite scaffold fabricated by incorporating GMs in collagen hydrogels on the 









MATERIALS AND METHODS 
A detailed description of all the materials and methods employed for 











Gelatin, acetone, glycine, hoechst 33258, ethylene di-amine tetra-acetic acid 
(EDTA), sodium chloride (NaCl), phosphate buffer saline (PBS), sodium 
hydrogen carbonate (NaHCO3), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid (HEPES), sodium hydroxide (NaOH), dexamethasone, indomethacin, 
isobutyl methyl xanthine (IBMX), Oil Red O, isopropyl alcohol, 
paraformaldehyde, ascorbic acid, β-glycerol phosphate, Alizarin red S, 
ammonium hydroxide (NH4OH), nicotinamide, hoechst, phalloidin-
tetramethylrhodamine B isothiocyanate (TRITC), ammonium chloride (NH4Cl), 
bovine serum albumin (BSA), saponin, all qPCR primers, growth factor reduced 
matrigel, 24 well transwell culture plates, heparin and endothelial cell growth 
supplement were obtained from Sigma (USA). Olive oil was purchased from 
Wako chemicals (Japan). Glutaraldehyde was purchased from Merck (USA). 
Dulbecco’s modified eagle’s medium (DMEM), fetal bovine serum (FBS), trypsin 
and antibiotics for cell culture were obtained from Hyclone (USA). Epidermal 
growth factor (EGF), basic fibroblast growth factor (bFGF), hepatocyte growth 
factor (HGF) and bFGF ELISA kit were purchased from Peprotech (USA). 
RNeasy mini kit for RNA extraction bought from Qiagen. Maxima first strand 
cDNA synthesis kit obtained from Fermentas, Thermo fisher (USA). SYBR 
FAST Biorad qPCR master mix was purchased from Kapa Biosystems (USA). 
Human umbilical vein endothelial cells (HUVEC) and F-12k medium were 
obtained from the American type culture collection (ATCC) (USA). Collagen 
type I obtained from Advanced biomatrix (USA). Collagenase type I and insulin 
were purchased from Gibco, Life technologies (USA). Antibodies for albumin, 
alpha-fetoprotein and cytokeratin 18 along with alkaline phosphatase assay kit 
were obtained from Abcam (USA). Pierce BCA protein assay kit for protein 




3.2. Fabrication and Characterization of cell-microsphere (ADSC-GM) 
constructs 
3.2.1. Gelatin microsphere fabrication and characterization 
Gelatin microspheres (GMs) were fabricated using a water-in-oil emulsion 
method (Zhu et al. 2008). Briefly, 4 g of gelatin was dissolved in 20 mL of water 
and heated up to 60 oC. 200 mL of olive oil was heated up to 40 oC. Gelatin was 
then added drop-wise into the olive oil, while stirring at 420 rpm with a 
mechanical stirrer (RW20; Ika Labortechnik, Staufen, Germany). The water-in-oil 
(w/o) emulsion was stirred for 10 min before being immersed into an ice bath to 
maintain the temperature at 10 oC and stirred for a further 30 min. 60 mL of 
chilled acetone was then added and the mixture was stirred for another 1 h. The 
GMs were extracted from the olive oil by a series of centrifuging and washing 
with chilled acetone. Crosslinking was carried out by immersing the microspheres 
in 150 mL of 10 mM glutaraldehyde solution and stirred at 420 rpm for 12 h at 4 
oC. Crosslinked microspheres were washed with deionized (DI) water and then 
suspended in 50 mM glycine solution to block the unreacted aldehyde groups for 
2 h at room temperature. The microspheres were then washed with acetone and air 
dried. Thus obtained GMs were stored at -20 oC for future use. 
The GMs were characterized for their sizes using an optical microscope and their 
surface morphology using a scanning electron microscope (SEM) (JSM-5600VL; 
JEOL, Tokyo, Japan). As GMs tend to swell by absorbing water, the sizes of 
microspheres were measured both in dry and in wet state, after saturation with 
sterile DI water for 3 h. Images were taken using a digital camera attached to the 
optical microscope and the sizes were analyzed by measuring the diameters of the 
microspheres using image pro software. For imaging under SEM, dry 
microspheres were mounted onto brass stubs using a two-sided adhesive tape and 
platinum coated for 40 s using Auto Fine Coater (JFC-1300; JEOL). 
3.2.2. ADSCs isolation and culture 
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ADSCs were isolated from adipose tissues obtained from patients undergoing 
liposuction with informed consent and approval from the Institutional Review 
Board, National University Hospital, Singapore. The obtained adipose tissues 
were processed for ADSCs isolation using an established protocol (Leong et al. 
2005). Briefly, the tissues were washed with phosphate buffer saline (PBS) on a 
separating sieve and treated with 0.075% collagenase type I for 1 h at 37 oC under 
shaking. Cells were pelleted out by centrifugation at 1200 x g, 4 oC for 10 min 
and plated in tissue culture flasks along with growth medium (DMEM containing 
10% fetal bovine serum and 1% antibiotics). After the cells were attached, the 
medium was removed, washed with PBS and replaced with fresh medium. The 
cells were cultured to 80% confluency and then passaged for cell expansion. 
ADSCs of passages 2 to 4 have been used for the experiments in this study. 
3.2.3. Cell seeding on gelatin microspheres 
GMs crosslinked with 10 mM glutaraldehyde were sterilized with 70% ethanol 
followed by complete washing with sterilized PBS. For differentiation 
experiments, the microspheres were then transferred to 12 well plates at 10 mg 
per well and 5x104 cells were then seeded onto the microspheres per well (i.e. 
5x103 cells per mg of microspheres).  For cell proliferation experiments, the 
microspheres were transferred to 24 well plates at 2 mg per well and 1x104 cells 
per well were subsequently seeded onto the microspheres. 
3.2.4. Total DNA quantification assay 
Total DNA quantification method was used to study the proliferation of ADSCs 
on GMs and on traditional 2D tissue culture dishes. ADSCs were cultured on the 
microspheres and on 2D over a period of 10 d and samples were collected on 
different time points for performing the assay. The culture samples were washed 
twice with PBS and the cells were lysed by incubating with ultrapure water 
followed by three freeze-thaw cycles. A solution of 1 μg/mL Hoechst 33258 in 10 
mM Tris-HCl (pH 7.4), 1 mM EDTA and 0.2 M NaCl was prepared and mixed 
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with the cell lysates to incubate in dark for 30 min. Subsequently fluorescent 
readings were measured using a microplate reader (Infinite M200, Tecan) at an 
excitation wavelength of 360 nm and an emission wavelength of 465 nm. 
3.2.5. Differentiation of ADSCs and characterization 
Following differentiation media were used to differentiate ADSCs both in 
monolayer and on GMs into adipogenic, osteogenic and hepatic lineages.  
For adipogenic differentiation, ADSCs were maintained in the adipogenic 
induction medium (Wall et al. 2007) comprising of growth medium supplemented 
with 1 µM dexamethasone, 5 µg/mL insulin, 100 µM indomethacin and 500 µM 
isobutyl methyl xanthine. Adipogenic differentiation was characterized by Oil 
Red O staining after three weeks of induction. To further confirm the 
differentiation, expression of adipogenic marker gene PPAR-γ was also analyzed 
using real time PCR. 
For osteogenic differentiation, ADSCs were maintained in the osteogenic 
induction medium (Wall et al. 2007) comprising of growth medium supplemented 
with 50 µM ascorbic acid, 0.1 µM dexamethasone and 10 mM β-glycerol 
phosphate. After three weeks of induction the cells were fixed with 4% 
paraformaldehyde and stained with Alizarin red S to observe the presence of 
mineralized matrix deposition. Real time PCR was also performed to analyze the 
gene expression of a key osteogenic transcription factor gene, RunX2. 
Hepatic differentiation was performed by culturing the ADSCs in serum free 
medium containing DMEM supplemented with 20 ng/mL epidermal growth 
factor (EGF) and 10 ng/mL basic fibroblast growth factor (bFGF) for 48 h. For 
the next two weeks, ADSCs were cultured in DMEM supplemented with 20 
ng/mL hepatocyte growth factor (HGF), 10 ng/mL bFGF and 4.9 mM 
nicotinamide (Talens-Visconti et al. 2007). After two weeks, the hepatic 
differentiation was characterized by studying the gene expression of albumin. 
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Presence of hepatic markers albumin, alpha-fetoprotein and cytokeratin18 was 
confirmed by performing immunofluorescence staining. 
3.2.6. Oil Red O Staining  
ADSCs differentiated towards adipogenic lineage both on 2D and on GMs were 
stained with Oil Red O for characterizing the differentiation. Prior to performing 
the staining, appropriate amount of Oil Red O solution was prepared. Firstly, a 
stock solution of 0.5% Oil Red O solution in isopropyl alcohol is prepared, which 
can be stored up to 3 months at room temperature upon protection from light. 
Working solution of Oil Red O was then freshly prepared by mixing 3 parts of 
stock solution to 2 parts of PBS. The working solution was then thoroughly mixed 
and left for 10 min. This solution was finally filter sterilized and used within 2 
hours of preparation.  
Once the Oil Red O working solution was prepared, the differentiation media was 
removed from all the wells and the samples were washed twice with PBS. ADSCs 
were then fixed using 4% paraformaldehyde for 1 h at room temperature and the 
samples were rinsed with PBS twice. 2 mL of Oil Red O working solution was 
then added to each well and incubated for 20 min at room temperature. The stain 
solution was removed and the samples were washed again with PBS twice. All 
the samples were finally examined under an optical microscope for visualization 
of lipid droplets inside differentiated ADSCs and their images were taken using a 
digital camera attached to the microscope.   
3.2.7. Alizarin red staining  
ADSCs differentiated towards osteogenic lineage both on 2D and on GMs were 
stained with Alizarin red S for characterizing the differentiation. Prior to 
performing the staining, appropriate amount of stain solution was prepared. 1 g of 
Alizarin red S was dissolved in 100 mL of DI water and pH of the solution was 
adjusted to be between 4.1 and 4.3 using 0.1% ammonium hydroxide. This 
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solution was then filter sterilized and used for staining, which can be stored up to 
3 months at room temperature upon protection from light.  
Once the Alizarin red stain solution was prepared, the differentiation media was 
removed from all the wells and the samples were washed twice with PBS. ADSCs 
were then fixed using 4% paraformaldehyde for 1 h at room temperature and the 
samples were rinsed with DI water twice. 2 mL of Alizarin red stain solution was 
then added to each well and incubated for 20 min at room temperature. The stain 
solution was removed and the samples were washed again with DI water twice. 
All the samples were finally examined under an optical microscope for 
visualization of mineralized matrix depositions by the differentiated ADSCs and 
their images were taken using a digital camera attached to the microscope.  
3.2.8. Real-time quantitative polymerase chain reaction (qPCR) 
Total RNA was extracted from ADSCs cultured both on tissue culture plates and 
on GMs using Qiagen RNeasy mini kit. Concentrations of the extracted total 
RNA was determined using Nanodrop 2000 spectrophotometer (Thermo 
Scientific). Complementary DNA (cDNA) was synthesized from the extracted 
RNA using Maxima first strand cDNA synthesis kit (Thermo Scientific). The 
obtained cDNA was used for qPCR which was performed in triplicates by using 
SYBR FAST Biorad qPCR master mix (Kapa Biosystems). The primers used in 
the qPCR are given in Table 3.1. Relative gene expression was found out using 






Table 3.1 Primer sequences used for qPCR experiments 

































3.2.9.  Immunofluorescence staining 
The ADSCs differentiated both in monolayer and on GMs were fixed with 4% 
paraformaldehyde for 20 min. The samples were then washed with PBS, 100 mM 
NH4Cl and again with PBS. Following this, cells were permeabilized in 0.1% 
W/V saponin for 15 min. Primary antibodies were diluted in blocking buffer 
consisting of 5% fetal bovine serum and 2% bovine serum albumin in PBS and 
were added to the culture samples for 1 h. The samples were subsequently washed 
thrice with PBS and incubated for 1 h with a solution containing secondary 
antibody, Hoechst and phalloidin diluted in blocking buffer. Finally, the samples 
were washed for six times with PBS and visualized under a confocal laser 
scanning microscope (CLSM) (C1 system, Nikon, Singapore). 
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3.2.10.   In vitro HUVEC-matrigel assay 
To test the in vitro pro-angiogenic activity of the ADSCs cultured on 2D and on 
GMs, HUVEC-matrigel assay was performed. HUVECs were co-cultured with 
ADSCs either cultured on 2D or on GMs and tube formation ability of HUVECs 
on matrigel was quantified. HUVECs alone without any co-culture with ADSCs 
were used as control.  24-well transwell culture plates were used for the co-culture 
experiments. HUVECs purchased from ATCC were maintained in growth 
medium consisting of F-12K medium supplemented with 0.1 mg/mL heparin, 
0.05 mg/mL endothelial cell growth supplement and 10% fetal bovine serum. 
For matrigel assay, ADSCs were initially cultured in the culture inserts either on 
2D or on GMs for two days and conditioned media were collected. On day 3 the 
bottom wells of the transwell plates were coated with growth factor reduced 
matrigel and incubated for 30 min at 37 oC for gelation. HUVECs were 
trypsinized and seeded onto matrigel coated wells at a density of 5x104 cells per 
well. The co-culture was performed for 24 h in medium containing both ADSC 
conditioned medium and HUVEC growth medium in 1:1 ratio. After 24 h, optical 
images were taken and quantitative measurements were made for tube lengths and 
number of branch points of the HUVEC tubules formed on matrigel using ImageJ 
software. 
3.3. Osteogenic induction of ADSCs in Col-GM composite scaffolds 
3.3.1. Fabrication of Col-GM scaffolds 
GMs were fabricated using a water-in-oil emulsion method and crosslinked with 
10 mM glutaraldehyde as described the section 3.2.1. Pure collagen gels were also 
synthesized using a previously described method (Liang et al. 2011). Briefly, pre-
chilled bovine collagen type I solution (3 mg/mL, PureCol, Advanced Biomatrix), 
growth medium containing ADSCs (50,000 cells per 1 mL volume of gel) and 
reconstitution solution were mixed in a ratio of 8:4:1. The reconstitution solution 
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was a mixture of 0.26 M of sodium hydrogen carbonate, 0.2 M 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) and 0.04 N of sodium 
hydroxide. The mixture was subsequently incubated at 37 oC for 4 h to form 3D 
collagen hydrogels (Col). To form Col-GM scaffolds, ADSCs were first seeded 
onto GMs as described in section 3.2.3 at a concentration of 50,000 cells per 10 
mg of GMs. This cell-microsphere mixture was first incubated in 200 µL of 
growth medium at 37 oC for 4 h for the cells to attach to the GMs. Then cell-
microsphere constructs were mixed with the pre-chilled collagen type I solution 
and reconstitution solution as described above to form the Col-GM scaffolds. 
ADSCs seeded only on GMs were used as control groups in the experiments as 
required.  
3.3.2. Rheological measurement of Col-GM scaffolds 
Rheological properties of the scaffolds were measured using an AR-G2 rheometer 
(TA instruments, New castle, USA) using parallel plates of diameter 40 mm at 37 
oC. Firstly, the scaffolds were formed by mixing respective pre-gel solutions and 
then added onto the rheometer. After a brief equilibration of the gels on the 
rheometer plates at 37 oC, rheological measurements were carried out. Dynamic 
strain sweeps were first carried out from 0.1% to 100% at an angular frequency of 
1 rad/s to find out the linear visco-elastic region. Following that, the strain was 
fixed at 1% and frequency sweeps were performed over the frequency range of 
0.1 – 10 rad/s.  
3.3.3. Immunofluorescence staining 
On various time points during a 10 d culture in growth medium, ADSCs cultured 
in Col-GM scaffolds were fixed with 4% paraformaldehyde for 20 min. The 
samples were then washed once with PBS, twice with 100 mM NH4Cl and again 
with PBS. Following this, cells were permeabilized in 0.1% W/V saponin for 15 
min. Hoechst and phalloidin-TRITC were diluted in blocking buffer consisting of 
5% fetal bovine serum and 2% bovine serum albumin in PBS and were added to 
the culture samples for 1 h. Finally, the samples were washed for six times with 
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PBS and visualized under a confocal laser scanning microscope (CLSM) (C1 
system, Nikon, Singapore). 
3.3.4. Real-time quantitative polymerase chain reaction (qPCR) 
Col-GM scaffolds on appropriate time points during the differentiation of ADSCs 
were first treated with collagenase type I solution (1,000 units/mL in PBS) at 37 
oC for 1 h to break the collagen matrix. Total RNA was subsequently extracted 
from all the samples and qPCR was performed according to the protocol 
described in the section 3.2.8. The primer sequences used for the qPCR are given 
in Table 3.2. 
Table 3.2 Primer sequences used for qPCR experiments 


















3.3.5. Encapsulation of bFGF in Col-GM scaffolds and in vitro release study 
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GMs were sterilized with 70% ethanol followed by complete washing with 
sterilized PBS and then were air dried for 5 h under sterile conditions. 100 µL of 
bFGF solution (1 ng/µL) was then added to 20 mg of such air dried GMs and 
were left for 5 h for the GMs to absorb the bFGF solution completely while 
swelling. These bFGF loaded GMs were then incorporated into collagen 
hydrogels fabricated as described above. For incorporating bFGF into collagen 
hydrogels, 100 ng of bFGF solution was prepared at appropriate concentration 
and mixed with collagen type I solution and reconstitution solution to form the 
hydrogel.  
To study the release profile, bFGF loaded scaffolds were suspended in 2 mL of 
DMEM and incubated at 37 oC for 14 days. At set time points, the supernatant 
was collected and replaced with fresh DMEM. The concentrations of bFGF in the 
collected supernatants were analyzed using an ELISA kit (Peprotech) according 
to manufacturer’s instructions. 
3.3.6. Alkaline phosphatase (ALP) activity  
ALP activity of all the Col-GM scaffolds was quantified on predetermined time 
points for assessing the osteogenic differentiation of ADSCs. A calorimetric assay 
kit (Abcam, Cambridge, UK) was used to evaluate the ALP activities. The kit 
uses p-nitrophenyl phosphate as substrate for ALP and its conversion to p-
nitrophenol can be analyzed by measuring the absorbance at 405 nm. Osteogenic 
medium from all the samples was aspirated and washed with PBS. 300 μL of lysis 
buffer provided with the kit was then added directly to all the samples and were 
incubated for 15 min. After confirming the cell lysis by checking under 
microscope, the samples were centrifuged at 13,000 x g for 3 min at 4 oC to 
remove the cell and scaffold debris. The supernatants were subsequently collected 
and ALP activities were measured according to manufacturer’s instructions. Total 
protein from all the samples was also quantified using Pierce BCA protein assay 
kit (Thermo scientific, Illinois, USA). ALP activities from different samples were 
further normalized with their respective total protein values.  
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3.4. Statistical analysis 
All the data presented in this study represents mean ± standard deviation values of 
three experiments, unless otherwise stated. Statistical differences between groups 
were found using Student’s t-test or One-way ANOVA. Differences with P<0.05 


















FABRICATION AND CHARACTERIZATION OF CELL-
MICROSPHERE CONSTRUCTS FORMED WITH HUMAN 
ADIPOSE DERIVED STEM CELLS AND GELATIN 
MICROSPHERES 
 
This chapter describes the strategy of cell-microsphere constructs 
(ADSC-GMs) as an in vitro 3D culture platform for human ADSCs 
and their properties such as proliferation, stemness, multi-lineage 
differentiation and pro-angiogenic potential. The work in this chapter 
addresses objective 1 described in chapter 1.This work has been 








Adipose derived stem cells (ADSCs) which have very similar characteristics to 
that of bone marrow mesenchymal stem cells (BMSCs) (Kern et al. 2006) are 
gaining increased interest because of their immense therapeutic potential evident 
from recent studies (Leong et al. 2006, Li et al. 2011, Lin et al. 2011, Tay et al. 
2011, Choi et al. 2012, Hwang et al. 2013a). However, many of the studies 
involving ADSCs have been performed on two dimensional (2D) tissue culture 
dishes which do not resemble the in vivo microenvironment. In addition, direct 
injection of such cell suspensions cultured on 2D have proven to be inefficient for 
regenerating tissues due to poor engraftment and lack of control over cell 
distribution inside body (Lee et al. 2008, Mooney et al. 2008). In many instances, 
most of the transplanted cells die shortly after implantation (Guerette et al. 1997, 
Emgard et al. 2003). Dearth of cell attachment sites and existence of ischemic 
environment due to poor vascularization might be the reasons for such cell death. 
Microcarriers designed as injectable cell delivery vehicles which can provide cell 
attachment sites and also aid in vascularizing regenerative tissue can overcome 
this problem. Such microcarriers can be used to deliver both cells as well as 
biomolecules simultaneously (Chen et al. 2010). Zhu et al. have previously 
employed basic fibroblast growth factor loaded gelatin microspheres (GMs) for 
culturing human umbilical vein endothelial cells (HUVECs) in a similar effort to 
promote vascularization for tissue implants (Zhu et al. 2008). GMs are well 
established drug delivery vehicles (Young et al. 2005) which have also been 
studied for their suitability in various tissue engineering applications (Zhu et al. 
2008, Baraniak et al. 2012, Leong et al. 2013).   In this chapter, we report 3D 
GMs as viable platforms for tissue engineering with human ADSCs. To this end, 
we studied the role of GMs in controlling stemness, angiogenic and 
differentiation properties of ADSCs, all of which are important factors for tissue 
regeneration. 
The regenerative capacity of ADSCs for clinical applications can be enhanced by 
promoting their stemness and angiogenic properties. Maintaining stemness 
improves the multi-lineage differentiation ability of ADSCs while pro-angiogenic 
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properties can be useful for vascularization of regenerating tissues. Recent studies 
have employed 3D spheroids for enhancing stemness, angiogenic and other 
functional properties of ADSCs as well as other cell types (Lin et al. 2008, Cheng 
et al. 2012, Laschke et al. 2013). Presence of stronger cell-cell interactions in 
spheroidal morphology was found to be the reason for such enhanced functional 
abilities. However, spheroids are associated with diffusional limitations and also 
lack cell-matrix interactions. Some other studies using microsphere scaffolds have 
shown that such strong cell-cell and cell-matrix interactions can also be generated 
by forming compact cell-microsphere constructs with superior control over cell 
behaviour (Khew et al. 2007, Zhu et al. 2007a, Zhu et al. 2007b, Zhu et al. 2008, 
Chen et al. 2012).  
Thus the objective of this study is to investigate whether the ADSCs can similarly 
form such cell-microsphere constructs (ADSC-GMs) with enhanced tissue 
regenerative abilities suitable for direct clinical use. To achieve this objective, we 
conducted experiments to test the ability of ADSC-GM constructs for three 
different aspects of tissue regeneration. Firstly, maintenance of stemness 
properties in the ADSC-GM constructs was studied. Recent studies have shown 
that well known pluripotent marker genes such as Oct4, Sox2, Nanog and Rex1 
play an important role in self-renewal and preserving differentiation abilities of 
ADSCs and BMSCs (Greco et al. 2007, Riekstina et al. 2009, Baer et al. 2010). 
Therefore, these four genes were selected to test the stemness properties and their 
gene expression was studied using quantitative polymerase chain reaction (qPCR) 
during the proliferation of ADSCs. Secondly, the multipotent differentiation 
abilities of ADSC-GMs were studied by inducing them towards adipogenic, 
osteogenic and hepatic lineages. Thirdly, pro-angiogenic ability of the constructs 
was also studied using an in vitro HUVEC-matrigel assay. HUVECs were co-
cultured with either ADSC-GMs or ADSCs on 2D and the tube formation ability 
of HUVECs on the matrigel was quantified. This ADSC-GM construct strategy 
for stem cell culture and delivery can be a promising approach for the use of adult 




4.2. Results  
4.2.1. Fabrication of Gelatin microspheres 
All the GMs fabricated were found to be spherical with smooth surfaces as shown 
under SEM (Figure 4.1c). The optical microscope images of the GMs in dry 
(Figure 4.1a) and wet (Figure 4.1b) conditions show the swelling nature of these 
hydrogel microspheres. Sizes of the microspheres sampled from a single batch of 
microspheres were measured and found to be 103.8 ± 27.5 µm when dry and 
145.7 ± 46.4 µm when swollen with a mean swelling ratio of 2.77.  
 
Figure 4.1 Optical microscope images of GMs in (a) dry and (b) wet condition. 
(c) SEM image of GMs showing the sphericity of the GMs and SEM image in the 
inset showing the smooth surface of the GMs. 
4.2.2. ADSC culture and proliferation on gelatin microspheres 
Figure 4.2a and b, show the optical microscope images of ADSC-GM constructs 
on day 3 and day 7 respectively. ADSCs seem to attach and spread well on the 
microspheres by day 3. Some of the elongated ADSCs tend to extend over 
individual microspheres bridging adjacent microspheres. By day 7, ADSCs 
became confluent over the microspheres, strengthening the bridges between 
microspheres to form large cell-microsphere clusters. To study the morphology of 
ADSC-GMs in detail, SEM (Figure 4.2c) and CLSM (Figure 4.2d) imaging of 
ADSC-GMs was performed after one week of culture. SEM images of ADSC-
GMs show differences in surface morphology from the plain GMs shown in 
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Figure 4.1c which has a smooth surface. That could be due to the GMs being 
covered with cells and extracellular matrix secreted by the cells. The presence of 
cells and the extracellular matrix helps in holding the ADSC-GM construct as an 
integral organoid graft. Such a coordinated bridging at the cellular level will 
further lead to higher hierarchical integrity.  From the CLSM images, actin 
filaments of ADSCs were seem to be stained with phalloidin-TRITC (red) and 
nucleus stained with Hoechst (blue). The image in Figure 2d clearly confirms the 
presence of ADSCs on microspheres and their spreading. 
To further study the proliferation of ADSCs on GMs, total DNA quantification 
assay was performed for microsphere cultures (Zhu et al. 2007b). A calibration 
curve was used to obtain the cell numbers on different days of culture as 
presented in Figure 4.3a. The results show that cell numbers increase from day 1 
to day 10 both on 2D and on GMs. ADSCs tend to proliferate faster on GMs as 
compared to 2D cultures as seen by their mean doubling times of around 2 days 
and 2.5 days respectively measured between day 3 and day 7 of the log phase. 
ADSCs can adhere better to GMs compared to the tissue culture plates because of 
the presence of cell adhesive moieties on gelatin and the GMs also provide a 
larger surface area compared to 2D cultures. These might be the reasons for the 
faster growth rate of ADSCs that is observed on GMs. The cell proliferation 
results obtained are in agreement with previous studies on microsphere scaffolds 




Figure 4.2 ADSCs cultured on GMs. Optical microscope images of ADSC-GMs 
on (a) day 3 and (b) day 7 of culture period. Black arrows showing the bridging of 
adjacent GMs by elongated ADSCs. (c) SEM and (d) CLSM images of ADSC-
GMs on day 7. For CLSM image cell actin was stained with phalloidin-TRITC 




Figure 4.3 (a) Proliferation of ADSCs on 2D (      ) and on GMs (      ) studied 
using total DNA quantification assay. Differences in cell numbers on 2D and 
GMs were not found to be statistically significant. (b) qPCR fold change values 
measured relative to day 0 control for stemness marker genes Oct4, Sox2, Nanog 
and Rex1 of ADSCs cultured on 2D and GMs after day 3 and day 7. Error bars 
represent SD (n=3); *P<0.05 (student’s t-test) compared to 2D group on day 3 
and †P<0.05 (student’s t-test) compared to 2D group on day 7.  
 
 
(       2D day 3;       GMs day 3;       2D day 7;       GMs day 7)     
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4.2.3. Expression of stemness marker genes on gelatin microspheres 
We studied the expression of well-known stemness marker genes Oct4, Sox2, 
Nanog and Rex1 using qPCR for ADSCs cultured both in monolayer and on 
GMs. It was found that ADSCs cultured on GMs expressed significantly higher 
amounts of Oct4, Sox2, Nanog and Rex1 as compared to the monolayer cultures 
shown in Figure 4.3b. Gene expression of all four genes studied seems to be 
upregulated on day 3 compared to day 0 controls in ADSC-GMs with mean fold 
changes of 2.4, 2.9, 2.3 and 13.1 for Oct4, Sox2, Nanog and Rex1 respectively. In 
contrast on 2D culture plates, there was a down regulation of all genes except for 
Rex-1 which was upregulated by 3.2 fold. The expression levels of Oct4 and 
Rex1 on ADSC-GMs were maintained even after one week of culture with 
average fold changes of 2.6 and 13 compared to day 0 controls. However, there 
was a decline in the expression levels of Sox2 and Nanog on day 7 as compared 
to day 3, possibly due to culturing in serum containing medium. Optimizing the 
media conditions might further enhance the gene expression of these stemness 
genes (Baer et al. 2010). Our results demonstrate that ADSCs cultured on 
traditional 2D tissue culture dishes tend to lose their stemness marker gene 
expression which are in agreement with other studies (Park et al. 2010a). On the 
contrary, ADSC-GMs can overcome that problem by providing an artificial stem 
cell niche which preserves the expression of stemness genes.  
4.2.4. Adipogenic and osteogenic differentiation of ADSCs 
ADSCs cultured both in monolayer and on GMs were able to differentiate into 
adipogenic and osteogenic lineages when maintained in the appropriate 
differentiation media. The differentiation was characterized by Oil red O and 
Alizarin red staining as shown in Figure 4.4. Enhanced mineralization was 
observed in ADSC-GMs as compared to 2D cultures on staining with Alizarin red 
(Figure 4.4c and d). ADSCs tend to mineralize the GMs during the process of 
osteogenic differentiation which will be advantageous when ADSC-GMs are used 
as in vivo delivery vehicles for bone regeneration. To further confirm and quantify 
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the differentiation, qPCR was performed to test the gene expression of respective 
differentiation markers, PPAR-γ for adipogenic and Runx2 for osteogenic 
differentiation. Markers for both lineages have shown significantly higher gene 
expression in ADSC-GMs as compared to ADSCs cultured in 2D by around 1.7 
times and 1.8 times for adipogenic and osteogenic markers respectively (Figure 
4.4e and f). Several studies have previously reported that microsphere scaffolds 
can enhance adipogenic and osteogenic differentiation of various kinds of stem 
cells (Park et al. 2010b, Moshaverinia et al. 2012, Yao et al. 2012). In agreement 
with those studies, our results also show that GMs also seem to be better 
platforms than 2D cultures for in vitro differentiation of ADSCs into adipogenic 
and osteogenic lineages. 
 
Figure 4.4 Optical microscope images of Oil Red O staining of ADSCs on (a) 2D 
and on (b) GMs showing adipogenic differentiation. Microscope images showing 
Alizarin red staining of ADSCs on (c) 2D and on (d) GMs for detection of 
osteogenic differentiation. qPCR fold change values measured relative to day 0 
control for adipogenic and osteogenic marker genes (e) PPAR-γ and (f) Runx2 






4.2.5. Hepatic differentiation of ADSCs 
ADSCs were also differentiated towards the hepatic lineage and characterized 
using immunofluorescence staining and qPCR. Figure 4.5a and b show the images 
taken using CLSM after the differentiated ADSCs on 2D and on GMs were 
stained with fluorescent hepatic marker antibodies for albumin, alpha-fetoprotein 
and cytokeratin18. Phalloidin-TRITC and Hoechst were used to stain actin 
filaments and nucleus respectively to show the cell morphology. ADSCs showed 
positive immuno-staining for all three key hepatic markers both on 2D and on 
GMs. qPCR results (Figure 4.5c) show that albumin expression in ADSC-GMs is 
almost two times to that of in 2D cultures although it is not statistically 
significant. Most of the previous studies that show hepatic differentiation of 
ADSCs were all performed on conventional 2D cultures (Banas et al. 2007, 
Talens-Visconti et al. 2007, Coradeghini et al. 2010). Consistent with those 
studies, we were also able to differentiate ADSCs into hepatic lineage on 2D. 
However, such hepatocytes generated on 2D cannot be used directly for in vivo 
applications. On the other hand, our results show that GMs can also support the 
hepatogenesis of ADSCs. Such hepatic constructs derived from ADSC-GMs can 




Figure 4.5 CLSM images of ADSCs differentiated towards hepatic lineage on (a) 
2D and on (b) GMs after 2 weeks. For all CLSM images cell actin was stained 
with phalloidin-TRITC and nucleus with Hoechst. Hepatic markers were stained 
with respective antibodies tagged with FITC (albumin (ALB), alpha-fetoprotein 
(AFP) and cytokeratin 18 (Cyt18)). The dotted circles show the microspheres. (c) 
qPCR fold change values of ADSCs differentiated on 2D and GMs measured 
relative to day 0 control for hepatic marker gene albumin. The differences in 
expression levels were not found to be statistically significant. Error bars 




Figure 4.6 (a) HUVEC tube formation in two dimensional matrigel assay. 
Representative images of HUVECs seeded on matrigel in co-culture with or 
without ADSC-2D or ADSC-GMs. (b) Quantification of tube like formations. 
Tube lengths and number of branch points were estimated from images taken 
from three experiments. Error bars represent SD. *P<0.05. ANOVA followed by 
Tukey-Kramer test was performed to find out statistical significance.    
4.2.6. Pro-angiogenic activity of ADSC-GMs 
Angiogenic activity of ADSCs cultured on 2D and on GMs was studied using two 
dimensional in vitro matrigel assay which is a highly specific assay for 
angiogenesis and is widely used as an in vitro method to evaluate pro-angiogenic 
factors (Auerbach et al. 2003, Ucuzian et al. 2007). HUVECs on matrigel were 
co-cultured either with ADSCs on 2D or with ADSC-GMs for 24 h and optical 
microscope images of HUVEC tubules formed were taken. Figure 4.6a shows the 
representative images of HUVEC tubules formed on matrigel in different culture 
samples. Angiogenic activity was further quantified by measuring the tube lengths 
and the number of branch points of HUVEC tubular networks. As shown in 
Figure 4.6b, ADSC-GMs were able to induce 1.6 times longer tubules with 2 
times more number of branch points as compared to ADSCs cultured on 2D. This 
shows the enhanced pro-angiogenic ability of ADSC-GMs compared to 2D 
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cultures. HUVECs alone without any co-culture with ADSCs were used as 
control for this study. Tubular formation of HUVECs in case of both the co-
culture samples i.e., either with ADSC-GMs or with ADSCs on 2D were 
significantly higher compared to the control, inducing 2 times and 1.2 times 
longer tubules with 3 times and 1.5 times more number of branch points 
respectively. This highlights the inherent pro-angiogenic properties of the 
ADSCs. Similar enhancement in the tubular formation ability of HUVECs on 
matrigel was also reported earlier when co-cultured with human MSCs 
immobilized within RGD-grafted alginate microspheres (Bidarra et al. 2010). 
4.3. Discussion 
In this study we demonstrated a strategy to assemble the ADSCs and GMs into 
cell-microsphere constructs which seem to have enhanced regenerative properties 
compared to ADSCs cultured on 2D. Stem cell properties such as proliferation, 
maintenance of stemness, differentiation and pro-angiogenic abilities play crucial 
role in different stages of tissue regenerative process and platforms that can 
enhance such properties will aid in accelerating the wound healing. Designing 
such regenerative systems using injectable delivery vehicles such as GMs will 
make them a favourable option for clinical practice than the implant systems that 
need more invasive surgical means. Injectability of similar cell-microsphere 
construct systems into animal models using a syringe has been demonstrated in 
previous studies (Chung et al. 2009, Woo et al. 2014). For example, Chung et al. 
have used 18G needles to inject their 3T3 L1 mouse preadipocyte cellular 
aggregates made using microsphere scaffolds for adipose tissue regeneration in 
mice (Chung et al. 2009). 
GMs have been employed in several previous studies for different tissue 
engineering applications such as cartilage tissue engineering (Garcia Cruz et al. 
2013), muscle regeneration (Hagiwara et al. 2013), bone tissue engineering 
(Tzouanas et al. 2014) and also for culturing HUVEC cells (Zhu et al. 2008) both 
under in vitro and in vivo conditions and were found to be very advantageous 
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scaffolds in terms of eliciting biological response as well as in regeneration of 
tissues. GMs are also being employed to provide biomolecular cues by releasing 
appropriate growth factors at desirable rates in a controlled fashion (Park et al. 
2005, Patel et al. 2008) and also as cell delivery vehicles (Lau et al. 2010). In 
addition, GMs are incorporated into cell aggregates (Bratt-Leal et al. 2011, 
Hayashi et al. 2011, Baraniak et al. 2012, Bratt-Leal et al. 2013) and cell sheets 
(Solorio et al. 2012b) to enhance the biological functions of respective systems. 
GMs are also widely studied by Prof Tabata’s group for several drug delivery and 
tissue engineering applications (Kimura et al. 2003, Ogawa et al. 2010, 
Nakaguchi et al. 2012, Ikeda et al. 2014) including clinical trials (Nitta et al. 
2009, Toyama et al. 2012) and thus regenerative systems made from them can 
have a better chance to succeed at clinical level compared to many other 
commercially available microcarriers. 
In addition to the advantages discussed above, GMs fabricated using the water-in-
oil emulsion technique also seem to be hydrogel in nature and have a tendency to 
swell by absorbing the liquid in which they are immersed. This swelling nature of 
GMs is very advantageous for encapsulating growth factors. Growth factors 
having opposite charge to that of the gelatin can be easily encapsulated using the 
principle of poly-ion complexation, just by dropping a small amount of growth 
factor solution onto the GMs (Young et al. 2005). The GMs will absorb the liquid 
completely during swelling and thus can have an almost quantitative 
encapsulation of the growth factor (Ikada et al. 1998). This permits GMs to be 
also used for spatio-temporal presentation of appropriate biomolecular signals in a 
controlled manner to influence stem cell fate (Solorio et al. 2012a). 
Previous studies indicate the low survival rate of stem cells upon direct injection 
of cell suspensions to the injured tissue, possibly due to lack of cell-matrix 
interactions leading to anoikis (Terrovitis et al. 2010). On the other hand, 
delivering stem cells with three dimensional platforms have been able to improve 
the survival rate of the stem cells and thus further improved their tissue 
regeneration ability (Zakharova et al. 2010, Parisi-Amon et al. 2013). In a similar 
effort, here we developed the 3D ADSC-GM constructs which can deliver 
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ADSCs with enhanced regenerative properties. In addition to the differentiation 
studies which are most commonly performed, we also studied the effect of such 
3D GM delivery vehicles on the stemness and angiogenic properties of ADSCs 
which are not well studied for such stem cell delivery constructs.  
Maintaining the stemness properties of ADSCs during their propagation is crucial 
for keeping their multi-lineage differentiation properties intact, especially when 
the final goal is to utilize them for tissue regenerative applications. Although, the 
factors associated with stemness maintenance in embryonic stem cells are 
relatively well studied, those that influence stemness in adult stem cells such as 
ADSCs are still unclear (Leong et al. 2012). In the case of embryonic stem cells, 
it is well known that transcription factors such as Oct4, Sox2 and Nanog play a 
key role in maintaining their pluripotency. However, recent studies also indicate 
the expression of these pluripotent marker genes in ADSCs (Baer et al. 2010, 
Cheng et al. 2012). Very recently, Heneidi et al. have isolated a new set of multi-
lineage differentiating cell population from adipose tissue which expresses many 
pluripotent marker genes (Heneidi et al. 2013). These studies highlight the 
growing interest towards identifying adult stem cells with pluripotent capabilities 
and for platforms which can enhance such properties. However, previous studies 
indicated the loss of stemness properties of MSCs when cultured in traditional 2D 
cultures (Park et al. 2010a) as also indicated by the downregulation of stemness 
marker gene expression of Oct4, Sox2 and Nanog in this work. This might lead to 
spontaneous differentiation of ADSCs into unwanted lineages (Tsai et al. 2010) 
and thus might significantly reduce the number of undifferentiated multipotent 
stem cells available for tissue regeneration. ADSC-GMs can overcome that 
problem by providing an artificial stem cell niche which preserves the expression 
of stemness genes.  
ADSCs ability to differentiate into adipogenic and osteogenic lineages has been 
well-established both on 2D (Bunnell et al. 2008b) and on 3D scaffolds (Li et al. 
2005). Utilizing such differentiated cells combined with various 3D scaffolds both 
for fat and bone tissue regeneration have also shown promising results (Chung et 
al. 2011, Hwang et al. 2013b, Zuk 2013). Previous studies have also employed 
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various kinds of microsphere scaffolds for MSC differentiation into adipogenic 
and osteogenic lineages. For example, PLGA microspheres coated with RGD 
peptide and loaded with BMP2 were used for osteogenic differentiation of human 
bone marrow MSCs (Park et al. 2010b). PLGA microspheres need to be coated 
with cell adhesive peptides to support cell adhesion and the growth factors need to 
be usually added during the fabrication of the microspheres which can 
significantly affect their biological activity. In another study, alginate 
microspheres were employed to encapsulate different kinds of stem cells and 
studied their adipogenic and osteogenic differentiation abilities (Moshaverinia et 
al. 2012). However, the alginate microspheres in this study were not modified 
with cell adhesion ligands, which affected the cell viabilities. Yao et al. has 
developed another method using a non-contact high voltage dispersion 
microsphere generating device to fabricate alginate-collagen microspheres, which 
showed enhanced adipogenic differentiation compared to 2D (Yao et al. 2012). 
Compared to other microsphere systems, GMs can support cell adhesion without 
any additional coating, easy to fabricate and even the growth factor encapsulation 
can be done much easily after the fabrication of microspheres without effecting 
their biological activity. 
Hepatic differentiation of ADSCs especially in 3D scaffolds has been relatively 
less studied. Although there are many studies which show hepatic differentiation 
of ADSCs using different inducing agents (Banas et al. 2007, Talens-Visconti et 
al. 2007, Coradeghini et al. 2010), almost all of these studies were performed on 
2D with very few focusing on 3D scaffolds (Wang et al. 2010). In this study, 
along with adipogenic and osteogenic differentiation of ADSCs, we have also 
shown differentiation of ADSCs to hepatic lineage both on 2D and on GMs. This 
allows ADSC-GM constructs to be used in forming organoid grafts for liver tissue 
engineering applications also along with being suitable for fat and bone 
regeneration.   
Along with replenishing the lost cells during tissue repair, stem cells can also play 
a significant role in vascularisation of the regenerating tissues through paracrine 
signalling (Hoch et al. 2012). Previous studies have shown that ADSCs can 
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influence angiogenesis in vivo (Matsuda et al. 2013) and can also enhance tube 
formation ability of endothelial cells in vitro (Merfeld-Clauss et al. 2010). ADSCs 
are known to secrete several growth factors at bioactive levels such as epidermal 
growth factor (EGF), vascular endothelial growth factor (VEGF), basic fibroblast 
growth factor (bFGF), platelet-derived growth factor (PDGF) and cytokines such 
as granulocyte colony stimulating factor (G-CSF), granulocyte/macrophage 
colony stimulating factor (GM-CSF), interleukin-6 (IL-6) and interleukin-8 (IL-8) 
(Salgado et al. 2010, Casadei et al. 2012) which have pro-angiogenic properties 
and have been reported to enhance HUVEC tubule formation under in vitro 
conditions (Lee et al. 2005, Chung et al. 2010, Botto et al. 2011). It has also been 
previously reported that the secretion profiles of such pro-angiogenic agents from 
ADSCs can be modulated by external conditions such as hypoxia (Rubina et al. 
2009) or by culturing the ADSCs in 3D culture systems (Liu et al. 2011). The 
enhanced formation of HUVEC tubular networks observed in our study when co-
cultured with ADSC-GMs compared to ADSC 2D cultures could be probably due 
to enhanced secretion of any of the above mentioned pro-angiogenic growth 
factors or cytokines under 3D conditions. Hence, the results obtained in our study 
suggest that angiogenic response of ADSCs can also be modulated through 3D 
culture conditions such as ADSC-GM constructs. 
Overall, this kind of a biomaterials approach of ADSC-GMs for treating damaged 
tissues can be an effective approach which can aid the ADSCs to differentiate into 
a specific lineage that helps in regaining the functional properties of the tissue as 
well as in improving the vascularisation which further helps in the proper supply 
of nutrients all over the tissue. In addition, future studies can focus on 
modifications in chemical and mechanical properties along with encapsulation of 
growth factors into GMs which might be able to further modulate the ADSCs 






This study demonstrates a simple strategy to form cell-microsphere (ADSC-GMs) 
constructs with strong cell-cell and cell-matrix interactions. Our findings show 
that this assembly of ADSC-GMs can preserve the stemness properties and 
enhance the differentiation abilities of ADSCs into adipogenic, osteogenic and 
hepatic lineages when compared to the traditional 2D cultures. Moreover, the 
ADSC-GMs also enhance the tubular network formation of HUVECs on matrigel 
and thus seem to augment the pro-angiogenic properties of ADSCs. This would 
lead to better vascularization of the regenerating tissue. We believe that 
employing these ADSC-GMs with such enhanced regenerative abilities can 















OSTEOGENIC INDUCTION OF HUMAN ADIPOSE DERIVED 
STEM CELLS IN A COLLAGEN HYDROGEL – GELATIN 
MICROSPHERE COMPOSITE SCAFFOLD 
 
This chapter describes the strategy of hydrogel-microsphere (Col-
GMs) composite scaffold for ADSC delivery. In addition, regulation of 
ADSC behaviour using mechanical and biomolecular cues provided 
by the Col-GM scaffolds with osteogenic model as a focus will also be 
presented in this chapter. The work in this chapter addresses 








Three dimensional (3D) scaffolds made of biomaterials have been an integral part 
of the tissue engineering strategies. They act as temporary replacements for 
natural extra-cellular matrices (ECM) found in vivo and also play a key role in 
providing the appropriate biochemical and biomechanical cues for cells in vitro. 
Controlling cell behaviour using these 3D scaffolds has become a major area of 
focus in tissue engineering, for which a wide variety of scaffolds have emerged. 
Among them include, two widely used scaffolds that are microspheres and 
hydrogels. In chapter 4, the study of cell-microsphere constructs (ADSC-GMs) 
has shown the influence that gelatin microsphere (GM) scaffolds can have on the 
tissue regenerative properties of ADSCs by enhancing their stemness, 
differentiation and angiogenic properties. However, maintaining such 
microsphere scaffolds at the injury site has been found to be challenging (Pannek 
et al. 2001, Lemperle et al. 2004) and in turn cell-cell and cell-matrix interactions 
present in the cell-microsphere constructs that are crucial for tissue integration 
can also get destroyed during the delivery process (Chen et al. 2011). To 
overcome such challenges associated with ADSC-GM constructs, we aimed to 
fabricate a hydrogel-microsphere composite scaffold system (Col-GMs) by 
encapsulating the ADSC-GM constructs into collagen hydrogels (Col). The 
encapsulating collagen hydrogel of the Col-GM system will enable gelling of the 
GMs together thereby restricting the ADSC-GMs to the injury site and also 
keeping the cell-cell interactions intact. Such a composite scaffold can therefore 
aid in making the ADSC-GMs suitable for injectable delivery as well as in the 
regulation of ADSC behaviour. In this work, we have chosen osteogenic 
induction of ADSCs as a model study, to establish the capability of Col-GM 
scaffolds in regulating the ADSC behaviour through presentation of various 
mechanical and biomolecular cues.  
As Col-GM scaffolds contain both the microspheres and hydrogel, the behaviour 
of encapsulated ADSCs will be governed by the properties of both the individual 
scaffolds. While microspheres are widely popular as carriers which can deliver 
both cells and growth factors simultaneously (Chen et al. 2010), hydrogels are 
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more known for providing a 3D in vivo mimicking environment (Slaughter et al. 
2009). In addition, the stiffness of a hydrogel environment also tends to play a 
role in determining stem cell fate with stiffer matrices enhancing the osteogenic 
differentiation (Engler et al. 2006). The Col-GM composite scaffolds that we 
intend to develop will be able to present hydrogel stiffness effect as mechanical 
cues to drive the ADSCs towards osteogenic lineage. In addition, to further 
accentuate the osteogenic induction, we also provided biomolecular cues to the 
ADSCs encapsulated in Col-GM scaffolds through basic fibroblast growth factor 
(bFGF) controlled release from GMs. bFGF is an important growth factor which 
regulates multiple regenerative processes simultaneously, such as cell 
proliferation, migration, angiogenesis and wound healing (Lee et al. 2002, 
Miyoshi et al. 2005, Hosseinkhani et al. 2006, Schmidt et al. 2006). In addition, 
many studies have also highlighted the potential of bFGF to enhance the 
osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) 
(Pitaru et al. 1993, Hanada et al. 1997, Oh et al. 2012) and in turn for bone 
regeneration (Jiang et al. 2010, Omata et al. 2012). 
In order to provide the mechanical cues through collagen hydrogels, we employed 
an unconventional approach i.e., variation in the matrix rigidity has been brought 
in by incorporating different amounts of GMs. Traditional crosslinking methods 
of enhancing hydrogel strength are usually cytotoxic and do not support in situ 
cell encapsulation. Alternatively, incorporating a harder phase such as 
microparticles into a hydrogel has been shown to enhance the overall rigidity of 
the composite scaffold acting as reinforcements for softer matrices (Jha et al. 
2009, Hu et al. 2011a).  
Thus, in this study, we investigated the effect of varying GMs concentration in 
reinforcing the collagen hydrogels and performed rheological studies on the bulk 
rigidity of the hydrogel. In addition, we also studied the effects of the mechanical 
cues on the osteogenic differentiation ability of the ADSCs. Differentiation was 
characterized by studying the gene expression of osteogenic marker genes bone 
morphogenetic protein 2 (BMP2), osteocalcin (OCN) and Runx2 and also by 
quantifying the alkaline phosphatase (ALP) activity. Further, we encapsulated 
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bFGF in the Col-GM scaffolds and also studied the effect of bFGF controlled 
release on the osteogenic differentiation of ADSCs and characterized as above. 
Overall, this study shows that Col-GMs can be used as an efficient delivery 
system for ADSCs as well as necessary growth factors simultaneously, with the 
capability to drive ADSCs towards osteogenic lineage through the means of 
mechanical and biomolecular cues. 
5.2. Results  
5.2.1. Characterization of mechanical properties of Col-GMs 
Dynamic mechanical analysis was performed using an AR-G2 rheometer to study 
the effect of incorporation of GMs on the mechanical properties of the collagen 
hydrogels. Two varieties of Col-GM scaffolds were prepared by incorporating 
varying amounts of GMs into the hydrogel – Col-10-GMs (10 mg of GMs per 1 
ml of collagen gel) and Col-20-GMs (20 mg of GMs per 1 ml of collagen gel). 
Strain sweep tests were conducted to find out the linear visco-elastic region 
(Figure 5.1). Later, frequency sweep studies (Figure 5.2a, b and c) of different 
scaffolds were performed by fixing the strain amplitude at 1%. Dynamic storage 
moduli (G’) of all the three scaffolds was found to be greater than their respective 
loss moduli (G”) over the entire frequency range studied (0.1 – 10 rad/s). This 
indicates all the three scaffolds are showing an elastic solid like behaviour (Liu et 
al. 2013). In addition, G’ of all the scaffolds kept increasing with the increase in 
frequency which is indicative of the reduced network structures relaxation at 
higher frequencies (Zhou et al. 2011). Also, the G’ values of all three scaffolds at 
a frequency of 1 rad/s were compared to assess their relative gel strengths as 
shown in Figure 5.2d. G’ of Col-20-GMs was found to be significantly higher 
compared to that of Col and Col-10-GMs by about 32 times and 5 times 
respectively. Another way to assess the gel strengths is by comparing their tan δ 
values which is the ratio of G” to that of G’ (Celli et al. 2007). A value of tan δ 
≤1, is indicative of a gel like material and lower the value of tan δ more elastic is 
the material, while tan δ ≥1 indicates a sol state. Figure 5.2e shows that tan δ of 
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all scaffolds is less than 1, confirming the gelation and also the values are 
significantly different from each other for all the scaffolds with Col-20-GMs 
being the stronger gel of all.  
 
Figure 5.1 Strain sweep study to identify the linear visco-elastic region showing 
G’ (storage modulus) values of collagen hydrogel (     ), Col-10-GMs (      ) and 
Col-20-GMs (     ). 
 
Figure 5.2 Rheological properties of Col-GM scaffolds. G’ (    ) – storage 
modulus and G” (    ) – loss modulus of (a) collagen hydrogel (b) Col-10-GMs 
(collagen hydrogel containing 10 mg of GMs) and (c) Col-20-GMs (collagen 
hydrogel containing 20 mg of GMs). (d) G’ (      ) and G” (      ) of replicate 
samples measured at a strain amplitude of 1% and an angular frequency of 1 
rad/s. (e) Tan δ values of different scaffolds. G’ and tan δ values indicating Col-
20-GMs having higher gel strength compared to Col-10-GMs and Col. Error bars 
represent SD (n=3); *P<0.05 (student’s t-test). 
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5.2.2. ADSC culture in Col-GM scaffolds 
ADSCs were cultured in Col-GM scaffolds over a period of 10 days. Optical 
microscope (Figure 5.3a) and CLSM images (Figure 5.3b) were taken on various 
time points during the culture to study the morphology and migratory behaviour 
of ADSCs. ADSCs were stained with Hoechst for nucleus (blue) and Phalloidin-
TRITC (red) for actin filaments before CLSM imaging. GMs being hydrogel in 
nature seem to absorb both the stains and could not be completely washed off, but 
clear distinction can still be made of the stained ADSCs from the GMs in the 
images shown in Figure 5.3b. As the ADSCs were initially seeded on the GMs 
and then loaded into the collagen hydrogels, on day 1 most of ADSCs seem to be 
adherent to the GMs. Cells started migrating into the surrounding gel space during 
day 4 to day 7 and found to completely populate the scaffold by day 10, covering 
both the GMs and the surrounding gel space. Previous work done by Chen et al. 
with a similar microsphere-hydrogel hybrid scaffold for neural tissue engineering 
has shown that this type of a composite scaffold can also aid in maintaining the 
cell-cell and cell-matrix interactions (Chen et al. 2011). Such interactions are 
prominent in the cell-microsphere scaffolds which were found to be crucial for 
maintaining the enhanced biological functions of the cells (Zhu et al. 2007a, Zhu 
et al. 2007b, Chen et al. 2012) and need to be preserved during cell delivery 
applications. With this motivation, in this study, we devised Col-GM scaffolds for 
ADSC culture. However, in slight contrast to the previous work with neuronal 
cells in the microsphere-hydrogel hybrid scaffolds, ADSCs have shown much 
more of a migratory behaviour into the surrounding gel space and populated the 
whole scaffold. As collagen is one of the most abundant proteins in the ECM of 
many of the human tissues, this phenomenon of ADSC migration into the 
surrounding collagen gel matrix seems to mimic the stem cell integration with the 
host tissue. This scaffold system can thus be effectively used to propagate the 
ADSCs for expanding their cell numbers and then to deliver those stem cells in an 




Figure 5.3 (a) Optical microscope and (b) Confocal laser scanning microscope 
(CLSM) images of human ADSCs cultured in Col-20-GM scaffolds over 10 days 
of culture showing cell adhesion and migratory behaviour. For CLSM images cell 
actin was stained with phalloidin-TRITC and nucleus with hoechst. 
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5.2.3. Osteogenic differentiation of ADSCs in Col-GM scaffolds 
ADSCs cultured in the Col-GM scaffolds were tested for their osteogenic 
differentiation ability upon maintaining in the differentiation media. The 
differentiation was characterized by studying the gene expression of osteogenic 
marker genes – BMP2, OCN and Runx2 (Figure 5.4) and ALP activity (Figure 
5.5). Gene expression of OCN and Runx2 was studied on day 7 and day 14. 
While for BMP2, as our preliminary experiments showed higher amounts of it 
being expressed in the initial stages of differentiation rather than later stages, we 
also studied their expression on day 4 along with on day 7 and day 14. BMP2 
expression seems to be highest on day 4 and tend to reduce by day 7. By day 14, 
BMP2 expression levels tend to reduce further or remain similar to day 7 in 
different scaffolds. For Runx2 the expression levels remained almost similar on 
day 7 and day 14 for all scaffolds and in case of OCN, which is a late marker 
gene, the expression levels have increased from day 7 to day 14 varying from 1.2 
to 1.9 times in different scaffolds. For all three genes that we studied, on all the 
time points, mostly both Col-10-GMs and Col-20-GMs seem to have similar 
expression pattern but have shown significantly increased expression compared to 
pure collagen hydrogels. Also, ADSCs in Col-10-GMs and Col-20-GMs have 
shown significantly higher expression of BMP2 and OCN on all the time points as 
compared to ADSCs cultured on GMs. In addition to the gene expression studies, 
ALP activity was also measured of the Col-GM scaffolds on day 7 and day 14 
(Figure 5.5). ALP activities in all the scaffolds found to be increasing from day 7 
to day 14. On both the time points, ALP activities were significantly higher in the 
Col-10-GM and Col-20-GM scaffolds compared to the Col gel by about 3.1 and 
6.4 times respectively. Further ADSCs differentiated in Col-20-GMs have shown 
twice the amount of ALP activity compared to the Col-10-GM samples. Overall, 
these results show that ADSCs have better osteogenic differentiation abilities in 





Figure 5.4 qPCR fold change values of osteogenic marker genes BMP2, OCN and 
Runx2 upon differentiating with osteogenic induction media in various scaffolds, 
measured relative to day 0 controls. β-actin used as housekeeping gene. Error bars 
represent SD (n=3); % and $ represents P<0.05 (student’s t-test) analyzed with 





Figure 5.5 ALP activity values of ADSCs upon differentiating with osteogenic 
induction media in various scaffolds. Glycine unit can be defined as the amount 
of enzyme causing the hydrolysis of 1 µmol of p-nitrophenyl phosphate per 
minute at pH 9.8 and 25 oC (glycine buffer). Error bars represent SD (n=3); % and 






5.2.4. bFGF encapsulation and in vitro release from Col-GM scaffolds 
GMs are well established drug delivery vehicles and have been used on numerous 
occasions to controlled release biomolecules for enhancing cellular activity 
(Kawai et al. 2000, Zhu et al. 2008, Jin et al. 2011, Hagiwara et al. 2013). In this 
study, we aim to use GMs as growth factor depots in Col-GM scaffolds to provide 
the ADSCs with necessary biomolecular cues in a controlled fashion. To achieve 
this objective, we first encapsulated bFGF into three scaffolds – Col, Col-20-GMs 
and GMs and studied its release profile (Figure 5.6) under in vitro conditions over 
a period of 14 days. The burst release which is an undesirable trait usually 
associated with controlled release of encapsulated growth factors from delivery 
systems (Joung et al. 2008) was found to be very minimal in all the three 
scaffolds that we studied releasing only 5.3%, 4.7% and 3.7% of the encapsulated 
bFGF in the first two days from Col, GMs and Col-20-GM scaffolds respectively. 
After 14 days of incubation, the scaffolds have released around 22.3%, 16.9% and 
12.8% of the encapsulated 100 ng of bFGF from Col, GMs and Col-20-GM 
scaffolds respectively. The amount of bFGF released by GMs over 14 days seems 





Figure 5.6 In vitro release profiles of bFGF from different scaffolds over a period 
of 14 days.                                                                                         
Error bars represent SD (n=3). Differences between the total bFGF released from 
all three scaffolds at each time point were found to be statistically significant, 
P<0.05 (one-way ANOVA). 
                 
 
5.2.5. Effect of bFGF controlled release on osteogenic differentiation of 
ADSCs in Col-GM scaffolds 
bFGF is a very well studied growth factor and known for its role in cell 
proliferation, angiogenesis and osteogenesis (Pitaru et al. 1993, Hosseinkhani et 
al. 2006, Schmidt et al. 2006). As there is no significant difference in the 
osteogenic marker gene expressions upon differentiation between Col-10-GMs 
and Col-20-GMs (Figure 5.4) and Col-20-GMs having shown higher ALP activity 
(Figure 5.5), we have chosen only the later scaffold for studying the effect of 
bFGF controlled release on osteogenic differentiation of ADSCs. In order to study 
this, bFGF was first encapsulated in Col, Col-20-GMs and GM scaffolds and 
ADSCs cultured in those scaffolds were induced towards osteogenic lineage. The 
differentiation was characterized by studying the gene expression of osteogenic 
marker genes OCN, Runx2 on day 7 and day 14 and that of BMP2 on day 4 along 
Col, GMs and             Col-20-GMs. 
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with day 7 and day 14 (Figure 5.7). A set of samples with free bFGF provided in 
the medium were used as control group. 
Our results show that there is high amount of BMP2 gene expression during the 
early phase of differentiation. For example, on day 4, average fold change values 
of BMP2 gene expression in both Col-20-GMs and GMs with encapsulated bFGF 
were found to be 62.3 and 27.3 with both of them being about 2.3 times higher 
than their respective control groups. By day 7, there was a reduction of expression 
varying from 2 to 6 times in different scaffolds which was further decreased by 
day 14. For OCN, as it is a late marker, there was no significant difference in the 
expression levels among the different scaffolds on day 7. By day 14, OCN 
expression was found to be higher in Col, Col-20-GMs and GMs encapsulated 
with bFGF by about 1.4, 3.6 and 1.7 times compared to their respective control 
groups. bFGF loaded Col-20-GMs were found to be showing highest OCN 
expression of all the scaffolds. In the case of Runx2 expression, by day 14, all the 
three scaffold types have similar expression levels with bFGF loaded scaffolds 
inducing higher expression levels compared to their respective control groups. 
The gene expression fold change values obtained in our study were found to be 
comparable to several previous studies (Gaharwar et al. 2012, Oh et al. 2012, 
Wang et al. 2014, Zhang et al. 2014). ALP activity values on both time points day 
7 and day 14, also show a similar trend to that of gene expression, with bFGF 
loaded scaffolds showing higher activity compared to their control groups (Figure 
5.8). ALP activities in all scaffolds found to be increased from day 7 to day 14. In 
addition, bFGF loaded Col-20-GMs have shown highest ALP activity compared 
to all other scaffolds. Overall, our gene expression studies for the three osteogenic 
marker genes along with the ALP quantification assay results show that, Col-20-
GMs encapsulated with bFGF tend to induce higher levels of osteogenic 




Figure 5.7 qPCR fold change values of osteogenic marker genes BMP2, OCN and 
Runx2 upon differentiating with osteogenic induction media in Col, Col-20-GM 
and GM scaffolds, measured relative to day 0 controls. β-actin used as 
housekeeping gene.     bFGF encapsulated in the scaffolds and        bFGF 
provided as a supplimentation in the media. Error bars represent SD (n=3); 
*P<0.05 (student’s t-test) analysed between bFGF encapsulated samples with 
respect to bFGF as media supplementation samples.  
 
Figure 5.8 ALP activity values of ADSCs upon differentiating with osteogenic 
induction media in Col, Col-20-GM and GM scaffolds. Glycine unit can be 
defined as the amount of enzyme causing the hydrolysis of 1 µmol of p-
nitrophenyl phosphate per minute at pH 9.8 and 25 oC (glycine buffer).                            
D    bFGF encapsulated in the scaffolds and    bFGF provided as a 
supplimentation in the media. Error bars represent SD (n=3); *P<0.05 (student’s 
t-test) analysed between bFGF encapsulated samples with respect to bFGF as 
media supplementation samples. 
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5.2.6. Adipogenic differentiation in Col-GM scaffolds 
In addition to osteogenic differentiation, we also wanted to study if the Col-GM 
scaffolds are also suitable for adipogenic differentiation of ADSCs. To this end, 
we induced the ADSCs encapsulated in pure collagen, Col-10-GMs, Col-20-GMs 
and GM scaffolds towards adipogenic lineage by culturing in adipogenic 
induction medium. We further characterized the differentiation by studying the 
gene expression of well known adipogenic marker gene, PPAR-γ using qPCR. In 
general, softer gels are known to promote adipogenic induction in stem cells as 
indicated by previous studies (Engler et al. 2006). In agreement with such studies, 
our qPCR results (Figure 5.9) also show that, higher levels of PPAR-γ was 
expressed in softer gels such as pure collagen hydrogels or Col-10-GMs 
compared to the relatively stiffer substrate like Col-20-GMs. Thus for fat specific 
applications, it is better to employ Col or Col-10-GM scaffolds rather than Col-
20-GMs. Further studies involving appropriate growth factor controlled release, 
will be able to give more insights into tuning the Col-GM scaffold properties for 
adipose tissue based applications.  
 
 
Figure 5.9 qPCR fold change values of adipogenic marker gene PPAR-γ upon 
differentiating with adipogenic induction media in various scaffolds, measured 
relative to day 0 controls. β-actin used as housekeeping gene. Error bars represent 
SD (n=3); % and $ represents P<0.05 (student’s t-test) analyzed with respect to 






This study describes a strategy to induce osteogenesis in human ADSCs using 
mechanical and biomolecular cues in a Col-GM composite scaffold. Col-GMs 
with varying hydrogel stiffness have been generated by varying the amount of 
GMs encapsulated which is employed as a mechanical cue. Further, the 
incorporated GMs were also used to controlled release bFGF. Along with 
providing a unique biomechanical microenvironment, such a composite scaffold 
can also overcome many disadvantages associated with the individual scaffolds as 
discussed in the introduction. However, most of the studies involving osteogenic 
induction of various stem cells have only been done either on microsphere or 
hydrogel scaffolds but very few studies (Wang et al. 2009a, DeVolder et al. 2012) 
focused on a microsphere-hydrogel composite scaffold system. Microsphere-
hydrogel scaffolds have also been employed previously for other applications 
such as cartilage repair (Sukarto et al. 2012) and drug delivery through blood-
brain barrier (Caicco et al. 2013). In this study, ADSCs encapsulated in the Col-
GM scaffolds were able to show enhanced osteogenic differentiation with 
increase in scaffold rigidity and have shown much more induction upon bFGF 
controlled release. 
GMs are well established drug delivery vehicles (Young et al. 2005) and also 
have been studied for many tissue engineering applications (Zhu et al. 2008, 
Baraniak et al. 2012, Leong et al. 2013). They have also been employed for 
various clinical trials successfully (Nitta et al. 2009, Toyama et al. 2012). 
Similarly, collagen hydrogels are also widely studied for tissue engineering 
applications and also many collagen based tissue engineering products have been 
commercialized by various companies for clinical applications ranging from 
cosmetics to bone regeneration (Malafaya et al. 2007). We believe, fabricating 
regenerative systems using such clinically successful materials would help in 
faster translation of those systems to the clinical stage. Further the Col-GMs 
developed here can also be delivered by injectable means which will be appealing 
to the medical field. 
75 
 
The scaffold design of Col-GMs allowed us to try and vary the matrix rigidity by 
varying the amount of GMs incorporated. The G’ values for all the three Col-GM 
scaffolds (Figure 5.2d) obtained through rheological studies, shows that 
incorporating GMs into collagen hydrogels enhances the strength of the 
hydrogels. Also, increasing the amount of GMs in the collagen hydrogel will 
further enhance the mechanical strength of the composite scaffold. These results 
were also supported by the tan δ data (Figure 5.2e). During deformation, GMs 
with proper homogenous dispersion in the hydrogel will aid in effective transfer 
of the load from polymer chains and thus might be responsible for enhancing the 
mechanical strength of the hydrogel. These results, in accordance with other 
studies (Jha et al. 2009, Hu et al. 2011a), confirm the strategy of enhancing matrix 
rigidity by incorporating a relatively harder phase into the hydrogel. Moreover, 
GMs incorporated into collagen hydrogels also had a similar reinforcing effect to 
that of nanofillers such as silicate nanoparticles (Gaharwar et al. 2012), clay 
nanotubes (Liu et al. 2013) or chitosan nanofibers (Zhou et al. 2011) in other 
hydrogel systems. The G’ values obtained for the Col-GMs were also similar to 
that obtained for a collagen hydrogel – PLGA microsphere composite system 
which was also employed for the osteogenic differentiation of mouse MSCs 
(DeVolder et al. 2012). The shear modulus (G) obtained in our study can also be 
mathematically converted into elastic modulus (E) in order to compare with the 
available literature of scaffolds employed for osteogenic differentiation. The 
mathematical relation between shear modulus and elastic modulus is given by E = 
2G(1+γ), where γ is the poisson’s ratio. For the collagen hydrogel used in this 
study manufacturer (Advanced biomatrix) has suggested a poisson’s ratio of 0.5 
and the relation between E and G as E = 3G. As per this relation, the average 
elastic moduli of the Col-GMs scaffolds were found to be 15.9 Pa, 75.6 Pa and 
513.8 Pa respectively for the collagen hydrogel, Col-10-GMs and Col-20-GMs. 
The typical scaffolds used for treating skeletal defects have the elastic modulus in 
the range of kilo to mega pascals (Hu et al. 2011b, Frohbergh et al. 2012, Tan et 
al. 2014). However, softer gels such as uncrosslinked collagen hydrogels have 
also been employed and were reported previously to be supportive of osteogenic 
differentiation (DeVolder et al. 2012, Oh et al. 2012). Such matrices can mimic 
the initial mesenchymal tissue conditions which initiate the osteogenic 
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differentiation of MSCs. In addition, although the initial rigidity of such softer 
gels is low, upon differentiation of MSCs for one week and further implantation 
in chicken chorioallantoic membranes (used as in vivo models for examining bone 
formation) the shear modulus values of the collagen hydrogel-PLGA microsphere 
composite scaffold constructs seem to significantly increase upto 35 kPa 
(DeVolder et al. 2012).   
For characterizing the osteogenic differentiation of ADSCs in various scaffolds 
we have studied gene expression of well known osteogenic marker genes BMP2, 
OCN and Runx2 using qPCR and also ALP assay. All the three markers chosen 
were important for bone development and osteogenic differentiation during 
different stages. BMP2 is a widely studied cytokine in the context of bone 
development and is known to enhance the osteogenic differentiation by regulating 
the expression of alkaline phosphatase, type I collagen and Runx2 (Kaur et al. 
2010). Runx2 is a transcription factor which plays a key role in the commitment 
of multipotent stem cells towards osteogenic lineage. It also acts as a positive 
regulator for the expression of bone matrix genes such as type I collagen, 
osteopontin, bone sialoprotein and Osteocalcin (Komori 2003). Previous studies 
employing Runx2 deficient mice have shown complete lack of bone and absence 
of osteoblasts in those mice, highlighting the important role Runx2 in osteogenic 
differentiation (Komori et al. 1997). Both BMP2 and Runx2 are early markers of 
differentiation and are expressed during the initial stages of differentiation. On the 
other hand, OCN is a late stage marker and expresses during the maturation stage 
of differentiation. Osteocalcin is a major noncollagenous protein present in the 
extracellular matrix of bone secreted by osteoblasts. It binds to hydroxyapatite 
and plays a key role in the matrix mineralization process. Other markers which 
are commonly employed to study osteogenic differentiation include osteopontin, 
type I collagen and bone sialoprotein. In addition, mineralization assays such as 
histochemical staining using alizarin red or von kossa stains are also used to 
assess the osteogenic differentiation of stem cells. 
Along with gene expression studies we have also performed ALP assay to study 
the osteogenic differentiation. ALP plays a key role in the process of 
77 
 
mineralization during osteogenesis. ALP increases the local concentration of 
inorganic phosphate which is needed for hydroxyapatite formation and 
mineralization and decreases the concentration of extracellular pyrophosphate, 
which acts as an inhibitor of mineralization. Several tissue engineering based 
studies involving osteogenesis have employed ALP enzyme activity measurement 
or histochemical staining of ALP as a standard assay for assessing the success of 
differentiation as increased ALP activity is considered as a good predictor of 
mineralization (Golub et al. 2007, Anderson et al. 2011, Vines et al. 2012, Simoes 
et al. 2013, Choi et al. 2014, Maia et al. 2014). 
The increase in the matrix rigidity of Col-GMs by GMs incorporation seems to 
favour the osteogenic differentiation of ADSCs. Previous studies have indicated 
the role of matrix elasticity in driving the stem cell differentiation towards 
osteogenic lineage (Engler et al. 2006). In this study, our gene expression and 
ALP assay results show that Col-20-GMs were able to induce more differentiation 
followed by Col-10-GMs and Col gels. This can be attributed to the mechanical 
properties of the scaffolds with stiffer ones inducing more differentiation. Our 
experiments of ADSCs cultured on GMs alone, presented in chapter 4, have 
shown that the differentiating ADSCs seem to mineralize the GMs (Figure 4.4d). 
This might probably aid in much better mineralization of the Col-GM scaffolds 
and in turn can enhance the osteogenic differentiation. Further, the stiffness effect 
of Col-GMs is also clearly evident as Col-20-GM scaffolds have shown higher 
amount of BMP2 and OCN gene expression along with higher ALP activity 
compared to GMs alone.  
To further enhance the osteogenic differentiation of ADSCs in Col-GMs we then 
employed the biomolecular cues. It has been shown previously that encapsulating 
growth factors into GMs is much easier compared to other microsphere scaffolds 
(Young et al. 2005). It can be done by simply adding a very little amount of 
concentrated growth factor solution onto the dry microspheres. GMs during the 
process of swelling tend to absorb the liquid completely along with all the growth 
factor without any loss (Zhu et al. 2008). In our controlled release experiments, 
the burst release of bFGF was found to be minimal during the first two days. 
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Previous studies indicate that bFGF tends to form strong complexes with both 
collagen and gelatin which might inhibit the burst release significantly during the 
early phases (Kanematsu et al. 2004, Young et al. 2005). As GMs are crosslinked 
with glutaraldehyde, they seem to release the encapsulated bFGF at a slower rate 
compared to pure collagen gel which is uncrosslinked. In addition, GMs tend to 
encapsulate growth factors by forming strong ionic complexes (Young et al. 
2005) allowing for the release to be more sustained. On the other hand, collagen 
used in this study has an isoelectric point in the zone of pH 7-8 (as informed by 
Advanced Biomatrix), which makes it neutral in charge at physiological pH and 
thus may not be able to form as strong ionic complexes with bFGF (isoelectric 
point of 9.6) as acidic gelatin (isoelectric point of 5.2) does in the case of GMs. 
This also leads to a relatively faster release of bFGF from collagen gels compared 
to GMs. However, the interactions of bFGF with collagen are not purely 
electrostatic alone and there might be other interactions which play a role but are 
not fully understood (Kanematsu et al. 2004). Such interactions might be 
responsible for having a sustained release from the Col hydrogels also, although 
the release is faster than the GMs. In the case of Col-20-GMs, the presence of a 
collagen gel layer surrounding the GMs as an additional barrier might be the 
cause for much slower release of encapsulated bFGF compared to either Col or 
GMs alone. However, none of the release profiles from any of the scaffolds have 
reached a plateau by the end of day 14 which suggests that these scaffolds can be 
used for long term controlled release applications. 
Such a controlled release of bFGF from the Col-GMs was also found to induce 
higher osteogenic differentiation in the encapsulated ADSCs compared to the 
samples where in bFGF was supplemented in the media. This clearly highlights 
the importance of bFGF presentation through delivery vehicles in a controlled 
manner, compared to merely adding in the medium. Even among the controlled 
releasing samples, Col-20-GMs which have shown the slowest bFGF release rate 
have induced higher differentiation. Col-20-GMs because of their slower release 
rate were able to keep more bFGF within the scaffold for a longer time, nearer to 
the cell membranes of ADSCs. Such encapsulated bFGF might thus have a better 
chance to interact with the corresponding receptors on cell membranes and induce 
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higher levels of osteogenic signals. On the other hand, the bFGF released out 
from the scaffolds will be of use during the in vivo applications, to elicit 
favourable responses such as vascularization in the surrounding injured tissue. 
Also, ALP activities of encapsulated ADSCs presented with bFGF either by 
controlled release or by supplementation in the medium (Figure 5.8) were found 
to be higher than the samples without bFGF (Figure 5.5) ranging from 1.4 times 
to almost 4 times in different scaffolds. This signifies the pro-osteogenic ability of 
bFGF which is supported by many studies in the literature (Pitaru et al. 1993, 
Hanada et al. 1997, Rider et al. 2008, Oh et al. 2012). 
Another interesting result obtained in this study is that bFGF controlled release 
was also able to induce high levels of BMP2 gene expression during initial stages 
of differentiation. Earlier studies using ectopic bone forming assays have 
indicated the importance of exposure to higher levels of BMP2 during initial 
stages for optimal bone formation (Bhakta et al. 2012). Such high levels of BMP2 
expressed by ADSCs can thus act in autocrine manner and further help to enhance 
bone regeneration. In addition, many studies have also highlighted the importance 
of supplying both bFGF and BMP2 for enhancing bone regeneration (Hanada et 
al. 1997, Su et al. 2013, Wang et al. 2013a). On the contrary, our study shows 
that, releasing bFGF from Col-20-GMs in a controlled fashion will actually 
induce the ADSCs to express BMP2 by themselves, in higher amounts, which 
might avoid or reduce the need to supply exogenous BMP2. However, more 
studies need to be conducted to confirm the effect of such increased BMP2 
expression on bone regeneration. 
Overall, this study shows that within Col-GM scaffolds, behaviour of ADSCs can 
be modulated using a combination of biomechanical and biomolecular cues to 
drive them towards osteogenic lineage. In addition, as many studies have 
indicated previously, collagen of the Col-GM scaffolds can also be conjugated 
with hydroxyapatite or β-tricalcium phosphate to further enhance the osteogenic 
differentiation of ADSCs (Komaki et al. 2006, Zhou et al. 2011). Although here 
we focused mainly on osteogenesis, the Col-GM scaffolds can also be fine tuned 
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for various other tissue engineering applications by incorporating the necessary 
cues, which can be of interest in future. 
5.4. Conclusions 
In this study we have shown that, mechanical properties of collagen hydrogels can 
be modulated by incorporation of GMs which can also act as growth factor 
depots. Further, thus formed Col-GM scaffolds can provide a unique 
biomechanical and biomolecular environment to drive the encapsulated ADSCs 
towards osteogenic lineage. Moreover, increase in hydrogel rigidity seem to have 
an enchancing effect on the osteogenic differentiation of ADSCs as Col-20-GMs 
induce more differentiation compared to either Col or GM scaffolds alone. Such 
enhanced osteogenic induction was further increased by the incorporation of 
bFGF into the scaffolds as evident from the ALP activity results. Interestingly, we 
also observed high levels of BMP2 gene expression by ADSCs upon bFGF 
presentation within Col-GM scaffolds. BMP2 is known to play crucial role in 
bone regeneration and inducing the ADSCs to express it by themselves might 
reduce the need to supply BMP2 exogenously. Overall, we believe that, this kind 
of an injectable, in situ gelling, composite stem cell delivery system loaded with 
appropriate growth factors has the potential to facilitate the much needed 













CONCLUSIONS AND RECOMMENDATIONS FOR FUTURE 
WORK 
This chapter provides an overview of the key findings from the studies 
presented in this thesis. In addition, a few recommendations which 








Stem cell therapies are creating exciting news time and again especially in the 
recent past with the outcomes of some of the clinical or experimental trials which 
were underway. Very recently, cure of HIV in two ‘Boston patients’ using stem 
cell transplantation has excited the whole world (Hayden 2013b). However, in 
five months time the HIV was found to be re-appeared again in those patients 
(Hayden 2013a). Similarly there are many other cases of clinical trials which have 
shown promising preliminary results but were still not been able to make it to 
next level (Chien 2004). There are also many instances where stem cell based 
clinical trials are failing or being terminated due to severe side effects (Kang et al. 
2004). The reasons for such failures need to be fully addressed for these therapies 
to go ahead and attain their true potential. The work presented in this thesis is an 
effort made towards addressing few such issues with a focus of using human 
ADSCs for stem cell based tissue regenerative applications.  
One of the main reasons for failure of cell therapies in general was found to be 
due to lack of cell adhesion sites once they were injected into the body as cell 
suspensions. Also the ischemic environment at the site of injury made the survival 
of injected cells difficult due to shortage of nutrient supplies. We tried to address 
this problem by developing cell-microsphere (ADSC-GMs) constructs that can 
provide cell adhesion sites for ADSCs and further investigated the tissue 
regenerative properties of these constructs including their pro-angiogenic 
potential. Further, to make these constructs feasible for a less invasive means of 
delivery, we encapsulated the cell-microsphere constructs in an injectable, in situ 
gelling collagen hydrogel to form hydrogel-microsphere composite scaffolds 
(Col-GMs). We also studied the effect of various mechanical as well as 
biomolecular cues provided by such a composite scaffold on the behaviour of 
ADSC-GMs. 
Major findings obtained in both the above mentioned studies are summarized in 
the following sections.  
6.1. Cell-microsphere constructs for tissue regenerative applications 
In this study, we have fabricated cell-microsphere constructs with strong cell-cell 
and cell-matrix interactions by combining ADSCs and GMs. We then investigated 
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the suitability of ADSC-GM constructs for tissue engineering applications by 
studying certain key properties which play crucial role in tissue regeneration, 
namely – stemness maintenance, multi-lineage differentiation and pro-angiogenic 
potential. 
Maintenance of stemness properties is crucial for stem cells to keep their multi-
lineage differentiation abilities intact. Loss of stemness might lead to spontaneous 
differentiation of stem cells and thus can significantly reduce the number of 
undifferentiated stem cells available for tissue regeneration. To test stemness 
properties of ADSC-GMs and ADSCs on 2D, we studied the gene expression of 
well known pluripotent marker genes Oct4, Sox2, Nanog and Rex1. We found 
that all these genes except Rex1 were consistently down-regulated in ADSCs 
cultured on tissue culture plates both on day 3 and day 7. On the contrary, ADSCs 
cultured on GMs have up-regulated the expression of all the genes that were 
studied on both time points. This shows that, ADSC-GMs provide a unique stem 
cell niche which helps in preserving the pluripotent gene expression of ADSCs. 
We then studied the multi-lineage differentiation abilities of ADSC-GMs by 
differentiating them into adipogenic, osteogenic and hepatic lineages and 
characterized using histo-chemical or immuno-fluorescent staining methods along 
with qPCR. Our staining results show that, ADSCs have successfully been able to 
differentiate into all the three lineages both on 2D and GMs. Further, qPCR 
studies for gene expression of lineage specific marker genes of all three lineages 
have shown that, ADSC-GMs express significantly higher amounts of the marker 
genes compared to ADSCs cultured on 2D. Differentiation of ADSCs towards 
adipogenic and osteogenic lineages has already been well established in various 
3D scaffolds. However, hepatic differentiation of ADSCs has been relatively less 
studied especially in 3D scaffolds. Thus, the results obtained in this study show 
that 3D ADSC-GMs can also be used for liver tissue engineering applications 
along with fat and bone regeneration. 
Finally, we also intended to study the pro-angiogenic potential of ADSC-GMs as 
vascularisation is also a key part of tissue regeneration. We have co-cultured the 
HUVECs (cultured on matrigel) either with ADSC-GMs or with ADSCs on 2D 
and studied the difference in the tube formation ability of the HUVECs among the 
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two groups. We found that, ADSC-GMs were able to induce significantly longer 
HUVEC tubules with more number of branch points compared to ADSCs on 2D 
indicating the superior pro-angiogenic activity of ADSC-GMs.  
Overall, this part of our work shows that ADSC-GMs can maintain the stemness 
properties and enhance the differentiation and angiogenic properties. Thus, 
compared to traditional cell suspensions of ADSCs that are cultured on 2D culture 
plates, employing the ADSC-GM constructs for tissue regeneration can accelerate 
the wound healing process and also aid in the vascularization of the injured tissue.  
6.2. Osteogenic induction of ADSCs in a hydrogel-microsphere composite 
scaffold 
To make the ADSC-GM constructs suitable for injectable delivery and to 
maintain their location at the wound site, we encapsulated these constructs in a 
collagen hydrogel to form Col-GM composite scaffolds. Further, by controlling 
the mechanical and biomolecular cues in such Col-GM scaffolds we also tried to 
drive the ADSCs towards osteogenic lineage. Hydrogel rigidity was the 
mechanical cue and bFGF controlled release was the biomolecular cue that were 
employed to enhance the osteogenic induction. We found that incorporating GMs 
can reinforce the mechanical strength of the collagen hydrogels. Hence, we also 
tried to vary the matrix rigidity by varying the amount of GMs incorporated into 
collagen hydrogels. 
Increase in matrix rigidity was found to enhance the osteogenic differentiation of 
ADSCs. Col-20-GMs which was found to have higher storage modulus compared 
to Col-10-GMs and Col gels, has also shown higher osteogenic induction in the 
encapsulated ADSCs.  
To further accentuate the differentiation, we have encapsulated bFGF into the 
Col-GM scaffolds. bFGF controlled release experiments have shown a sustained 
release profile from all the three scaffolds with Col-20-GMs releasing at a much 
slower rate compared to GMs and Col gel. In addition, Col-20-GMs loaded with 
bFGF have also shown higher osteogenic differentiation. With slower release 
rates, Col-20-GMs were able to maintain higher amounts of bFGF within the 
scaffold for a longer time which thus might have better chance to interact with the 
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corresponding receptors on cell membranes and induce higher levels of 
osteogenic signals.  
We also observed that, controlled release of bFGF was able to induce high levels 
of BMP2 gene expression in the encapsulated ADSCs during initial stages of 
differentiation. BMP2 is a growth factor well known for its pro-osteogenic 
activity (Bhakta et al. 2012). Many previous studies also indicated the synergistic 
effect of bFGF and BMP2 on bone regeneration (Hanada et al. 1997, Su et al. 
2013). By inducing ADSCs to express BMP2 through bFGF controlled release, 
our scaffold system seems to be similar to dual delivery of bFGF and BMP2 
which can have a positive impact on bone regeneration.    
Overall, this study shows that by appropriately controlling the mechanical and 
biomolecular cues in the Col-GM composite scaffolds the differentiation of 
ADSCs towards a particular lineage can be enhanced, as we have shown here for 
osteogenic lineage. Thus, we believe, with the advantages of injectable delivery 
and regulating ADSC behaviour, the Col-GM scaffolds can aid in the transition of 
ADSC therapies to clinical stage.  
6.3. Recommendations for future work 
6.3.1. Modulating Col-GM scaffolds for other tissue engineering applications  
The study presented in chapter 5 of this thesis mainly focused on osteogenic 
induction of ADSCs in Col-GM scaffolds. However, these scaffolds can also be 
fine-tuned for other tissue engineering applications by incorporating the necessary 
cues for a particular lineage. Appropriate mechanical cues can be provided by 
varying the amount of incorporated GMs accordingly. In addition, biocompatible 
crosslinkers which support in situ cell encapsulation (Liang et al. 2011) can also 
be employed if further increase in the matrix rigidity is required. Similarly, 
appropriate growth factors which promote differentiation towards a particular 
lineage can also be loaded into GMs and released at desirable rates.  
As a preliminary study, we attempted to differentiate ADSCs in Col-GM 
scaffolds towards adipogenic lineage and characterized the differentiation by 
studying the gene expression of well-known adipogenic marker gene, PPAR-γ 
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using qPCR. As shown in Figure 5.9, we observed that, higher levels of PPAR-γ 
was expressed in softer gels such as pure collagen hydrogels or Col-10-GMs 
compared to the stiffer substrates like Col-20-GMs and GMs which is in 
agreement with the previous studies that have shown that softer gels can promote 
adipogenic induction in stem cells (Engler et al. 2006).  
These studies involving osteogenic and adipogenic differentiation of ADSCs  
highlights the adaptability of the Col-GM scaffolds which further allows for 
designing the scaffolds, specific to different kinds of tissue engineering 
applications.   
6.3.2. In vivo studies 
All the tissue engineering approaches need to be tested in animal models to 
validate the results obtained under in vitro conditions and to confirm whether 
similar behaviour will be seen when injected in vivo. Many significant results 
were presented in this thesis which can contribute to the advancement of ADSC 
therapies and will be of interest to study if similar results can be obtained under in 
vivo conditions. For example, it will be interesting to study if the enhanced pro-
angiogenic properties of ADSC-GMs (chapter 4) will also hold good under in 
vivo conditions. Further, it will also be of interest to study if the higher BMP2 
expression observed in bFGF loaded Col-GM scaffolds (chapter 5) can have a 
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